dimethylarsinic acid - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	dimethylarsinic acid	go back to main search page
Accession:	CHEBI:48765	browse the term
Definition:	The organoarsenic compound that is arsenic acid substituted on the central arsenic atom with two methyl groups.
Synonyms:	related_synonym:	CACODYLIC ACID; Dimethylarsinate; Formula=C2H7AsO2; InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5); InChIKey=OGGXGZAMXPVRFZ-UHFFFAOYSA-N; Kakodylsaeure; Me2As(=O)OH; SMILES=C[As](C)(O)=O; [As(CH3)2O(OH)]
	alt_id:	CHEBI:29839; CHEBI:48764
	xref:	Beilstein:1736965; CAS:75-60-5; Drug_Central:3058; Gmelin:130562; KEGG:C07308
	xref_mesh:	MESH:D002101
	xref:	PDBeChem:CAD; PMID:11379771; PMID:11549254; PMID:21342701; PMID:21457993; PMID:21608259; PPDB:2879; Reaxys:1736965; Wikipedia:Cacodylic_acid
	cyclic_relationship:	is_conjugate_acid_of CHEBI:16223

show annotations for term's descendants Sort by:
Rat (995) Mouse (1141) Human (1018) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (995)

dimethylarsinic acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of A2M mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA

PMID:34876320 PMID:37567419

NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786

G

acetoacetyl-CoA synthetase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AACS mRNA

NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954

G

alanine and arginine rich domain containing protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AARD mRNA

NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:83,364,204...83,369,317

G

ATP binding cassette subfamily B member 1A

increases expression
decreases expression

Cacodylic Acid results in increased expression of ABCB1A mRNA; Cacodylic Acid results in increased expression of ABCB1A protein
Cacodylic Acid results in decreased expression of ABCB1A mRNA

PMID:16436460 PMID:17720352

NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709

G

ATP binding cassette subfamily C member 1

increases expression
increases transport
decreases response to substance
affects transport

Cacodylic Acid results in increased expression of ABCC1 mRNA; Cacodylic Acid results in increased expression of ABCC1 protein
ABCC1 protein results in increased transport of Cacodylic Acid
ABCC1 protein results in decreased susceptibility to Cacodylic Acid
ABCC1 protein modified form affects the transport of Cacodylic Acid

PMID:16436460 PMID:29752257

NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114

G

ATP binding cassette subfamily C member 2

increases expression

Cacodylic Acid results in increased expression of ABCC2 mRNA; Cacodylic Acid results in increased expression of ABCC2 protein

NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238

G

ATP binding cassette subfamily C member 3

increases expression

Cacodylic Acid results in increased expression of ABCC3 mRNA; Cacodylic Acid results in increased expression of ABCC3 protein

NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595

G

ATP binding cassette subfamily C member 4

increases transport
increases export
affects export

ABCC4 protein results in increased transport of Cacodylic Acid
ABCC4 protein results in increased export of Cacodylic Acid
ABCC4 gene SNP affects the export of Cacodylic Acid

PMID:24870404 PMID:25752797 PMID:27659809

NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283

G

ATP binding cassette subfamily C member 9

decreases expression

Cacodylic Acid results in decreased expression of ABCC9 mRNA

NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356

G

ABI family member 3 binding protein

decreases expression

Cacodylic Acid results in decreased expression of ABI3BP mRNA

NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA

NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472

G

acetylcholinesterase

decreases activity

Cacodylic Acid results in decreased activity of ACHE protein

NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651

G

acyl-CoA thioesterase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT1 mRNA

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163

G

acyl-CoA thioesterase 12

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT12 mRNA

NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536

G

acyl-CoA oxidase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOX2 mRNA

NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160

G

acrosin binding protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ACRBP mRNA

NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:157,841,841...157,864,213

G

actinin, alpha 1

increases expression

Cacodylic Acid results in increased expression of ACTN1 mRNA

NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251

G

ADAM metallopeptidase with thrombospondin type 1 motif, 19

decreases expression

Cacodylic Acid results in decreased expression of ADAMTS19 mRNA

NCBI chr18:52,346,448...52,531,245
Ensembl chr18:52,347,428...52,530,509

G

ADAM metallopeptidase with thrombospondin type 1 motif, 2

decreases expression

Cacodylic Acid results in decreased expression of ADAMTS2 mRNA

NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADAMTS4 mRNA

NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065

G

ADAM metallopeptidase with thrombospondin type 1 motif, 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADAMTS6 mRNA

NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298

G

adhesion G protein-coupled receptor G1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADGRG1 mRNA

NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

decreases expression

Cacodylic Acid results in decreased expression of ADH1 mRNA

NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892

G

adiponectin, C1Q and collagen domain containing

decreases expression

Cacodylic Acid results in decreased expression of ADIPOQ mRNA

NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564

G

adrenomedullin

increases expression
multiple interactions

Cacodylic Acid results in increased expression of ADM mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADM mRNA

PMID:32052077 PMID:34876320

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654

G

adrenoceptor alpha 2B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRA2B mRNA

NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355

G

adrenoceptor beta 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADRB1 mRNA

NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259

G

adrenoceptor beta 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRB2 mRNA

NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512

G

ALF transcription elongation factor 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AFF3 mRNA

NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:40,404,375...40,857,247

G

alpha-fetoprotein

increases expression

Cacodylic Acid results in increased expression of AFP mRNA

NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480

G

anterior gradient 3, protein disulphide isomerase family member

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AGR3 mRNA

NCBI chr 6:52,643,391...52,666,638
Ensembl chr 6:52,643,391...52,666,638

G

angiotensin II receptor-associated protein

decreases expression

Cacodylic Acid results in decreased expression of AGTRAP mRNA

NCBI chr 5:158,507,427...158,519,036
Ensembl chr 5:158,508,749...158,519,036

G

AT hook, DNA binding motif, containing 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AHDC1 mRNA

NCBI chr 5:145,228,228...145,294,170
Ensembl chr 5:145,228,227...145,294,145

G

aryl hydrocarbon receptor

multiple interactions

AHR mutant form inhibits the reaction [Cacodylic Acid results in increased expression of CYP1A1 protein]; Cacodylic Acid results in decreased expression of and affects the localization of AHR protein
Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 protein]

PMID:24161444 PMID:28134025

NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568

G

aryl-hydrocarbon receptor repressor

decreases expression

Cacodylic Acid results in decreased expression of AHRR mRNA

NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673

G

alpha-2-HS-glycoprotein

decreases expression

Cacodylic Acid results in decreased expression of AHSG mRNA

NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999

G

autoimmune regulator

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of AIRE mRNA

NCBI chr20:10,636,058...10,651,060
Ensembl chr20:10,636,123...10,651,060

G

adenylate kinase 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AK4 mRNA

NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618

G

aldo-keto reductase family 7, member A2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA

NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909

G

AKT serine/threonine kinase 1

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of AKT1 mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of AKT1 protein

PMID:23192986 PMID:32890875

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

albumin

decreases expression

Cacodylic Acid results in decreased expression of ALB mRNA

NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836

G

aldehyde dehydrogenase 1 family, member A1

increases expression

Cacodylic Acid results in increased expression of ALDH1A1 mRNA; Cacodylic Acid results in increased expression of ALDH1A1 protein

PMID:33211169 PMID:37567419

NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961

G

aldolase, fructose-bisphosphate C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA

NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066

G

alpha-kinase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA

NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157

G

angiopoietin like 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANGPTL7 mRNA

NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:158,932,794...158,937,324

G

ankyrin repeat domain 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919

G

ANKRD40 C-terminal like

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD40CL mRNA

NCBI chr10:79,227,791...79,236,365
Ensembl chr10:79,231,211...79,235,324

G

ANTXR cell adhesion molecule 1

decreases expression

Cacodylic Acid results in decreased expression of ANTXR1 mRNA

NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232

G

annexin A8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA

NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043

G

amine oxidase, copper containing 3

multiple interactions
increases expression
decreases expression

OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of AOC3 mRNA]
Cacodylic Acid results in decreased expression of AOC3 mRNA

PMID:17441966 PMID:37567419

NCBI chr10:86,272,757...86,280,702

G

apolipoprotein E

affects response to substance
multiple interactions

APOE protein affects the susceptibility to Cacodylic Acid
AS3MT protein affects the reaction [APOE protein affects the susceptibility to Cacodylic Acid]

NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932

G

apolipoprotein L9a

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL9A mRNA

NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649

G

amyloid beta precursor protein

multiple interactions
increases expression

Cacodylic Acid results in increased cleavage of and affects the secretion of APP protein mutant form; Cacodylic Acid results in increased expression of and affects the localization of APP protein mutant form
Cacodylic Acid results in increased expression of APP protein

NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561

G

aquaporin 7

increases expression

Cacodylic Acid results in increased expression of AQP7 mRNA

NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642

G

androgen receptor

decreases expression

Cacodylic Acid results in decreased expression of AR mRNA

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

amphiregulin

multiple interactions
increases expression

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AREG mRNA
Cacodylic Acid results in increased expression of AREG mRNA

PMID:34876320 PMID:37567419

NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535

G

ADP-ribosylation factor 6

increases expression

Cacodylic Acid results in increased expression of ARF6 mRNA

NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114

G

Rho GTPase activating protein 15

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP15 mRNA

NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:27,989,633...28,600,265

G

Rho GTPase activating protein 21

increases expression

Cacodylic Acid results in increased expression of ARHGAP21 mRNA

NCBI chr17:83,348,673...83,472,202
Ensembl chr17:83,348,673...83,472,444

G

Rho GTPase activating protein 25

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP25 mRNA

NCBI chr 4:119,896,844...119,974,982
Ensembl chr 4:119,896,844...119,974,982

G

Rho GTPase activating protein 28

decreases expression

Cacodylic Acid results in decreased expression of ARHGAP28 mRNA

NCBI chr 9:107,832,584...107,998,030
Ensembl chr 9:107,833,330...107,998,000

G

Rho GTPase activating protein 30

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP30 mRNA

NCBI chr13:83,822,290...83,843,634
Ensembl chr13:83,822,283...83,854,885

G

Rho GTPase activating protein 45

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP45 mRNA

NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268

G

Rho GTPase activating protein 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA

NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:115,850,654...115,902,093

G

Rho GDP dissociation inhibitor beta

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA

NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658

G

Rho guanine nucleotide exchange factor 38

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARHGEF38 mRNA

NCBI chr 2:221,610,212...221,739,841
Ensembl chr 2:221,613,070...221,740,079

G

ADP-ribosylation factor like GTPase 5C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARL5C mRNA

NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002

G

ADP-ribosylation factor like GTPase 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA

NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,157,586...31,166,699

G

arrestin domain containing 4

increases expression

Cacodylic Acid results in increased expression of ARRDC4 mRNA

NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290

G

arsenite methyltransferase

multiple interactions
increases expression

[AS3MT gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid; [AS3MT gene polymorphism affects the susceptibility to Arsenic] which results in increased abundance of Cacodylic Acid; [AS3MT protein polymorphism results in increased metabolism of arsenite] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein results in increased metabolism of arsenite] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid
AS3MT protein affects the reaction [APOE protein affects the susceptibility to Cacodylic Acid]
Cacodylic Acid results in increased expression of AS3MT protein

PMID:22868225 PMID:24845704 PMID:28728140 PMID:32650499 PMID:36399430

NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872

G

ankyrin repeat and SOCS box-containing 14

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB14 mRNA

NCBI chr16:2,095,567...2,123,259
Ensembl chr16:2,095,644...2,115,135

G

ankyrin repeat and SOCS box-containing 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB4 mRNA

NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:33,506,992...33,544,630

G

assembly factor for spindle microtubules

increases expression

Cacodylic Acid results in increased expression of ASPM mRNA

NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755

G

aspartic peptidase, retroviral-like 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASPRV1 mRNA

NCBI chr 4:119,077,415...119,078,887
Ensembl chr 4:119,077,356...119,078,379

G

activating transcription factor 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

activating transcription factor 4

increases expression

Cacodylic Acid results in increased expression of ATF4 mRNA

PMID:16122865 PMID:23221991

NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446

G

activating transcription factor 7 interacting protein 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA

NCBI chr10:5,403,099...5,445,989
Ensembl chr10:5,403,105...5,446,142

G

ATPase phospholipid transporting 10D (putative)

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA

NCBI chr14:35,911,728...36,012,549
Ensembl chr14:35,912,141...36,012,564

G

ATPase H+ transporting V0 subunit a4

increases expression

Cacodylic Acid results in increased expression of ATP6V0A4 mRNA

NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:66,760,159...66,842,110

G

ATPase copper transporting beta

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP7B mRNA

NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636

G

arginine vasopressin receptor 1A

decreases expression

Cacodylic Acid results in decreased expression of AVPR1A mRNA

NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215

G

axin 2

decreases expression

Cacodylic Acid results in decreased expression of AXIN2 mRNA

NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231

G

Beta-1,3-galactosyltransferase 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of B3GALT5 mRNA

NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166

G

BCL2-associated agonist of cell death

increases expression

Cacodylic Acid results in increased expression of BAD mRNA
Cacodylic Acid results in increased expression of BAD mRNA; Cacodylic Acid results in increased expression of BAD protein

PMID:16122865 PMID:22246474

NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823

G

B-cell scaffold protein with ankyrin repeats 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BANK1 mRNA

NCBI chr 2:224,530,475...224,800,420
Ensembl chr 2:224,530,475...224,800,405

G

Btg3 associated nuclear protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA

NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738

G

BCL2 associated X, apoptosis regulator

increases expression

Cacodylic Acid results in increased expression of BAX mRNA

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

branched chain ketoacid dehydrogenase kinase

decreases expression

Cacodylic Acid results in decreased expression of BCKDK mRNA

NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633

G

BCL2, apoptosis regulator

increases expression

Cacodylic Acid results in increased expression of BCL2 mRNA; Cacodylic Acid results in increased expression of BCL2 protein

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

Bcl2-like 1

increases expression

Cacodylic Acid results in increased expression of BCL2L1 mRNA

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479

G

BCL6 co-repressor-like 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BCORL1 mRNA

NCBI chr X:127,516,504...127,584,529
Ensembl chr X:127,537,538...127,584,087

G

brain expressed X-linked 3

increases expression

Cacodylic Acid results in increased expression of BEX3 mRNA

NCBI chr X:99,273,270...99,274,799
Ensembl chr X:99,273,161...99,274,800

G

bifunctional apoptosis regulator

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA

NCBI chr10:1,552,019...1,585,040
Ensembl chr10:1,552,072...1,585,038

G

basic helix-loop-helix family, member e41

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA

NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468

G

baculoviral IAP repeat-containing 5

increases expression
multiple interactions

Cacodylic Acid results in increased expression of BIRC5 mRNA; Cacodylic Acid results in increased expression of BIRC5 protein
Cacodylic Acid inhibits the reaction [sodium arsenite results in increased expression of BIRC5 protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [Cacodylic Acid results in increased expression of BIRC5 mRNA]

NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380

G

BLK proto-oncogene, Src family tyrosine kinase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BLK mRNA

NCBI chr15:37,626,746...37,665,053
Ensembl chr15:37,627,039...37,665,031

G

basic helix-loop-helix ARNT like 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA

NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231

G

bone morphogenetic protein 1

decreases expression

Cacodylic Acid results in decreased expression of BMP1 mRNA

NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776

G

bone morphogenetic protein 5

decreases expression

Cacodylic Acid results in decreased expression of BMP5 mRNA

NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925

G

bone morphogenetic protein receptor type 1A

increases expression

Cacodylic Acid results in increased expression of BMPR1A mRNA

NCBI chr16:9,736,390...9,829,825
Ensembl chr16:9,736,630...9,780,616

G

BOC cell adhesion associated, oncogene regulated

decreases expression

Cacodylic Acid results in decreased expression of BOC mRNA

NCBI chr11:56,122,697...56,198,060
Ensembl chr11:56,122,750...56,198,059

G

BCL2 family apoptosis regulator BOK

increases expression

Cacodylic Acid results in increased expression of BOK mRNA

NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476

G

Bri3 binding protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA

NCBI chr12:31,176,742...31,188,563
Ensembl chr12:31,173,971...31,188,572

G

Bruton tyrosine kinase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTK mRNA

NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853

G

B and T lymphocyte associated

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA

NCBI chr11:55,563,683...55,588,187
Ensembl chr11:55,564,899...55,587,181

G

C1q and TNF related 3

multiple interactions
decreases expression

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA
Cacodylic Acid results in decreased expression of C1QTNF3 mRNA

PMID:34876320 PMID:37567419

NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433

G

complement C1r

decreases expression

Cacodylic Acid results in decreased expression of C1R mRNA

NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484

G

complement C1s

decreases expression

Cacodylic Acid results in decreased expression of C1S mRNA

NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303

G

complement C7

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of C7 mRNA

NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535

G

similar to human chromosome 19 open reading frame 38

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AB124611 mRNA

NCBI chr 8:20,061,494...20,095,705
Ensembl chr 8:20,078,639...20,095,696

G

complement C9

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of C9 mRNA

NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338

G

calcium voltage-gated channel subunit alpha1 I

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CACNA1I mRNA

NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688

G

calcitonin receptor like receptor

decreases expression

Cacodylic Acid results in decreased expression of CALCRL mRNA

NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910

G

calmodulin 2

increases expression

Cacodylic Acid results in increased expression of CALM2 mRNA

NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
Ensembl chr15:7,091,567...7,104,287

G

calumenin

increases expression

Cacodylic Acid results in increased expression of CALU mRNA

NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593

G

calcium/calmodulin-dependent protein kinase IG

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAMK1G mRNA

NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556

G

cyclase associated actin cytoskeleton regulatory protein 1

increases expression

Cacodylic Acid results in increased expression of CAP1 mRNA

NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769

G

calpain 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAPN3 mRNA

NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858

G

calpain 9

increases expression

Cacodylic Acid results in increased expression of CAPN9 mRNA

NCBI chr19:52,549,448...52,586,413
Ensembl chr19:52,549,448...52,586,413

G

carbonic anhydrase 12

increases expression

Cacodylic Acid results in increased expression of CA12 mRNA

NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440

G

carbonic anhydrase 13

increases expression

Cacodylic Acid results in increased expression of CAR13 mRNA

NCBI chr 2:86,928,401...86,959,525
Ensembl chr 2:86,928,383...86,959,525

G

carbonic anhydrase 3

decreases expression

Cacodylic Acid results in decreased expression of CAR3 mRNA

PMID:17441966 PMID:37567419

NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280

G

caspase recruitment domain family, member 11

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARD11 mRNA

NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112

G

capping protein regulator and myosin 1 linker 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARMIL2 mRNA

NCBI chr19:33,571,255...33,586,783
Ensembl chr19:33,574,257...33,586,965

G

caspase 12

increases expression

Cacodylic Acid results in increased expression of CASP12 mRNA; Cacodylic Acid results in increased expression of CASP12 protein

NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037

G

caspase 2

increases expression

Cacodylic Acid analog results in increased expression of CASP2 protein

NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379

G

caspase 3

multiple interactions
increases activity
increases response to substance
increases expression

benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [CASP3 protein results in increased susceptibility to Cacodylic Acid]; Buthionine Sulfoximine inhibits the reaction [Cacodylic Acid results in increased activity of CASP3 protein]
Cacodylic Acid results in increased expression of CASP3 mRNA
Cacodylic Acid analog results in increased activity of CASP3 protein; Cacodylic Acid results in increased activity of CASP3 protein
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CASP3 mRNA

PMID:15276415 PMID:16122865 PMID:19465042 PMID:23192986 PMID:23994116

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

caspase 6

affects binding

CASP6 protein binds to Cacodylic Acid analog

NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502

G

caspase 8

multiple interactions
increases response to substance

benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP8 protein results in increased susceptibility to Cacodylic Acid]

NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542

G

caspase 9

multiple interactions
increases response to substance

benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP9 protein results in increased susceptibility to Cacodylic Acid]

NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626

G

catalase

increases expression
multiple interactions
decreases activity
increases activity

Cacodylic Acid results in increased expression of CAT mRNA
[CAT protein results in decreased oxidation of dimethylarsinous acid] which results in decreased chemical synthesis of Cacodylic Acid; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [Cacodylic Acid results in increased activity of CAT protein]
Cacodylic Acid results in decreased activity of CAT protein

PMID:16122865 PMID:18619986 PMID:24095718 PMID:32474354

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

cation channel, sperm associated 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CATSPER4 mRNA

NCBI chr 5:146,427,682...146,447,346
Ensembl chr 5:146,427,683...146,446,942

G

caveolin 2

decreases expression

Cacodylic Acid results in decreased expression of CAV2 mRNA

NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244

G

coiled-coil domain containing 122

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC122 mRNA

NCBI chr15:52,407,717...52,470,163
Ensembl chr15:52,407,717...52,470,163

G

coiled-coil domain containing 162

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC162 mRNA

NCBI chr20:45,044,891...45,237,905
Ensembl chr20:45,032,752...45,236,193

G

coiled-coil domain containing 71-like

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCDC71L mRNA

NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:48,960,191...48,960,841
Ensembl chr 6:48,960,191...48,960,841

G

coiled-coil domain containing 78

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC78 mRNA

NCBI chr10:14,808,355...14,812,284
Ensembl chr10:14,807,710...14,812,282

G

coiled-coil domain containing 80

decreases expression

Cacodylic Acid results in decreased expression of CCDC80 mRNA

NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137

G

coiled-coil domain containing 87

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA

NCBI chr 1:202,135,021...202,137,717
Ensembl chr 1:202,134,963...202,138,337

G

coiled-coil domain containing 92B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA

NCBI chr10:59,479,798...59,501,486
Ensembl chr10:59,479,743...59,501,495

G

C-C motif chemokine ligand 11

decreases expression

Cacodylic Acid results in decreased expression of CCL11 mRNA

PMID:32052077 PMID:37567419

NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926

G

C-C motif chemokine ligand 21

decreases expression

Cacodylic Acid results in decreased expression of CCL21 mRNA

NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686

G

C-C motif chemokine ligand 22

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA

NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400

G

C-C motif chemokine ligand 26

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of CCL26 mRNA

NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335

G

cellular communication network factor 1

multiple interactions
decreases expression

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCN1 mRNA
Cacodylic Acid results in decreased expression of CYR61 mRNA

PMID:34876320 PMID:37567419

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cyclin A2

increases expression

Cacodylic Acid results in increased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B2

increases expression

Cacodylic Acid results in increased expression of CCNB2 mRNA

NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874

G

cyclin C

increases expression
multiple interactions

Cacodylic Acid results in increased expression of CCNC mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CCNC mRNA]

NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584

G

cyclin D1

increases expression

Cacodylic Acid results in increased expression of CCND1 mRNA; Cacodylic Acid results in increased expression of CCND1 protein

PMID:12151359 PMID:17481689 PMID:24832369

NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602

G

cyclin D2

affects expression

Cacodylic Acid affects the expression of CCND2 mRNA

NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495

G

C-C motif chemokine receptor 2

decreases expression

Cacodylic Acid results in decreased expression of CCR2 mRNA

NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100

G

C-C motif chemokine receptor 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR6 mRNA

NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603

G

C-C motif chemokine receptor 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR7 mRNA

NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309

G

CD180 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD180 mRNA

NCBI chr 2:33,855,940...33,870,046
Ensembl chr 2:33,855,991...33,899,936

G

Cd2 molecule

increases expression
multiple interactions

Cacodylic Acid results in increased expression of CD2 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA

PMID:16122865 PMID:34876320

NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:188,710,900...188,724,026

G

CD22 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD22 mRNA

NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322

G

Cd28 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD28 mRNA

NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685

G

CD36 molecule

decreases expression

Cacodylic Acid results in decreased expression of CD36 mRNA

NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903

G

CD37 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA

NCBI chr 1:95,719,171...95,724,662
Ensembl chr 1:95,719,190...95,724,648

G

Cd4 molecule

decreases expression

Cacodylic Acid results in decreased expression of CD4 mRNA

NCBI chr 4:157,668,878...157,695,366

G

CD40 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD40 mRNA

NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534

G

CD46 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD46 mRNA

NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445

G

Cd5 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD5 mRNA

NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313

G

CD52 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD52 mRNA

NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348

G

Cd53 molecule

multiple interactions
decreases expression

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD53 mRNA
Cacodylic Acid results in decreased expression of CD53 mRNA

PMID:34876320 PMID:37567419

NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:194,352,139...194,399,657

G

Cd6 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD6 mRNA

NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634

G

Cd68 molecule

increases expression

Cacodylic Acid results in increased expression of CD68 mRNA

NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697

G

Cd69 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD69 mRNA

NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542

G

CD74 molecule

decreases expression

Cacodylic Acid results in decreased expression of CD74 mRNA

NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003

G

CD79a molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79A mRNA

NCBI chr 1:80,493,581...80,497,936
Ensembl chr 1:80,493,581...80,497,935

G

CD79b molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79B mRNA

NCBI chr10:91,239,354...91,242,500
Ensembl chr10:91,239,356...91,242,625

G

CD83 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD83 mRNA

NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083

G

CD84 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD84 mRNA

NCBI chr13:84,327,580...84,367,153
Ensembl chr13:84,327,553...84,362,076

G

CD86 molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD86 mRNA

NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818

G

cell division cycle 123

increases expression

Cacodylic Acid results in increased expression of CDC123 mRNA

NCBI chr17:72,459,270...72,503,316
Ensembl chr17:72,459,282...72,503,316

G

cell division cycle 37, HSP90 cochaperone

increases expression

Cacodylic Acid results in increased expression of CDC37 mRNA

NCBI chr 8:19,677,400...19,690,761
Ensembl chr 8:19,671,938...19,690,809

G

CDC42 effector protein 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CDC42EP2 mRNA

NCBI chr 1:203,202,000...203,210,891
Ensembl chr 1:203,201,873...203,210,897

G

cell division cycle 5-like

increases expression

Cacodylic Acid results in increased expression of CDC5L mRNA

NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450

G

cadherin 1

increases expression

Cacodylic Acid results in increased expression of CDH1 mRNA

PMID:16122865 PMID:17481689

NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775

G

cadherin 13

affects expression

Cacodylic Acid affects the expression of CDH13 mRNA

NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459

G

cadherin 4

increases expression
multiple interactions

Cacodylic Acid results in increased expression of CDH4 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CDH4 mRNA]

NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:166,525,099...167,003,371

G

cadherin 8

decreases expression

Cacodylic Acid results in decreased expression of CDH8 mRNA

NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,494,174...5,895,669

G

cyclin-dependent kinase 9

increases expression

Cacodylic Acid results in increased expression of CDK9 mRNA

NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410

G

cyclin dependent kinase like 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA

NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276

G

cyclin-dependent kinase inhibitor 1A

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of CDKN1A mRNA; Cacodylic Acid results in decreased expression of CDKN1A protein
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CDKN1A mRNA

PMID:12151359 PMID:17481689 PMID:23192986

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 1C

decreases expression

Cacodylic Acid results in decreased expression of CDKN1C mRNA

NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048

G

cyclin-dependent kinase inhibitor 2A

decreases expression
decreases methylation

Cacodylic Acid results in decreased expression of CDKN2A mRNA
Cacodylic Acid results in decreased methylation of CDKN2A promoter alternative form

PMID:16122865 PMID:23073540

NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149

G

cyclin-dependent kinase inhibitor 2B

decreases expression

Cacodylic Acid results in decreased expression of CDKN2B mRNA

NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050

G

CEA cell adhesion molecule 6

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of CEACAM6 mRNA

NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:80,416,531...80,434,668

G

CCAAT/enhancer binding protein gamma

decreases expression

Cacodylic Acid results in decreased expression of CEBPG mRNA

NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569

G

CECR2, histone acetyl-lysine reader

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CECR2 mRNA

NCBI chr 4:153,890,310...153,998,078
Ensembl chr 4:153,890,206...153,993,451

G

cadherin, EGF LAG seven-pass G-type receptor 3

decreases expression

Cacodylic Acid results in decreased expression of CELSR3 mRNA

NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354

G

cell migration inducing hyaluronidase 1

increases expression

Cacodylic Acid results in increased expression of CEMIP mRNA

NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415

G

centromere protein E

increases expression

Cacodylic Acid results in increased expression of CENPE mRNA

NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669

G

centromere protein F

increases expression

Cacodylic Acid results in increased expression of CENPF mRNA

NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669

G

carboxylesterase 2F

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CES2F mRNA

NCBI chr19:7,527...14,898
Ensembl chr19:7,527...14,898

G

cilia and flagella associated protein 47

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CFAP47 mRNA

NCBI chr X:43,264,687...43,616,607
Ensembl chr X:43,263,490...43,616,852

G

complement factor D

increases expression
multiple interactions

Cacodylic Acid results in increased expression of CFD mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CFD mRNA]

NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053

G

chondroadherin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHAD mRNA

NCBI chr10:79,512,170...79,515,941
Ensembl chr10:79,511,931...79,515,940

G

choline O-acetyltransferase

increases activity

Cacodylic Acid results in increased activity of CHAT protein

NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093

G

checkpoint kinase 2

increases expression

Cacodylic Acid results in increased expression of CHEK2 mRNA

NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286

G

chitinase 3 like 1

increases expression

Cacodylic Acid results in increased expression of CHI3L1 mRNA

NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787

G

chondrolectin

decreases expression

Cacodylic Acid results in decreased expression of CHODL mRNA

NCBI chr11:17,654,137...17,676,450
Ensembl chr11:17,654,206...17,676,441

G

cysteine and histidine rich domain containing 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA

NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162

G

cholinergic receptor nicotinic alpha 9 subunit

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHRNA9 mRNA

NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192

G

carbohydrate sulfotransferase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CHST3 mRNA

NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807

G

component of inhibitor of nuclear factor kappa B kinase complex

increases expression

Cacodylic Acid results in increased expression of CHUK mRNA; Cacodylic Acid results in increased expression of CHUK protein

NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065

G

circadian associated repressor of transcription

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIART mRNA

NCBI chr 2:183,419,819...183,424,845
Ensembl chr 2:183,419,819...183,423,313

G

class II, major histocompatibility complex, transactivator

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA

NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440

G

cartilage intermediate layer protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA

NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:65,777,281...65,792,251

G

cold inducible RNA binding protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIRBP mRNA

NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818

G

CDC28 protein kinase regulatory subunit 2

increases expression

Cacodylic Acid results in increased expression of CKS2 mRNA

NCBI chr17:13,570,611...13,575,770

G

cardiotrophin-like cytokine factor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA

NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605

G

C-type lectin domain containing 7A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLEC7A mRNA

NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897

G

clusterin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLU mRNA

NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315

G

cannabinoid receptor 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CNR2 mRNA

NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548

G

ciliary neurotrophic factor receptor

decreases expression

Cacodylic Acid results in decreased expression of CNTFR mRNA

NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392

G

cochlin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COCH mRNA

NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109

G

collagen type XI alpha 2 chain

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL11A2 mRNA

NCBI chr20:4,786,932...4,816,598
Ensembl chr20:4,786,929...4,815,985

G

collagen type XIV alpha 1 chain

decreases expression

Cacodylic Acid results in decreased expression of COL14A1 mRNA

NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214

G

collagen type XV alpha 1 chain

decreases expression

Cacodylic Acid results in decreased expression of COL15A1 mRNA

NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591

G

collagen type I alpha 1 chain

decreases expression

Cacodylic Acid results in decreased expression of COL1A1 mRNA

NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624

G

collagen type I alpha 2 chain

decreases expression

Cacodylic Acid results in decreased expression of COL1A2 mRNA

NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867

G

collagen type III alpha 1 chain

decreases expression

Cacodylic Acid results in decreased expression of COL3A1 mRNA

NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547

G

collagen type VI alpha 1 chain

decreases expression

Cacodylic Acid results in decreased expression of COL6A1 mRNA

NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597

G

collagen type VII alpha 1 chain

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of COL7A1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL7A1 mRNA

PMID:17441966 PMID:34876320

NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252

G

collectin sub-family member 12

decreases expression

Cacodylic Acid results in decreased expression of COLEC12 mRNA

NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618

G

collagen like tail subunit of asymmetric acetylcholinesterase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COLQ mRNA

NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107

G

cartilage oligomeric matrix protein

increases expression

Cacodylic Acid results in increased expression of COMP mRNA

NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845

G

coronin 1A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CORO1A mRNA

NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534

G

coactosin-like F-actin binding protein 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA

NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689

G

carboxypeptidase D

decreases expression

Cacodylic Acid results in decreased expression of CPD mRNA

NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491

G

carboxypeptidase M

decreases expression

Cacodylic Acid results in decreased expression of CPM mRNA

NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220

G

cleavage and polyadenylation specific factor 4-like

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CPSF4L mRNA

NCBI chr10:98,741,816...98,756,069
Ensembl chr10:98,743,649...98,751,590

G

carboxypeptidase X (M14 family), member 1

multiple interactions
decreases expression

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA
Cacodylic Acid results in decreased expression of CPXM1 mRNA

PMID:34876320 PMID:37567419

NCBI chr 3:117,588,532...117,595,330
Ensembl chr 3:117,588,532...117,595,330

G

complement C3d receptor 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CR2 mRNA

NCBI chr13:106,678,579...106,716,595
Ensembl chr13:106,685,413...106,716,235

G

cAMP responsive element binding protein 3-like 1

decreases expression

Cacodylic Acid results in decreased expression of CREB3L1 mRNA

NCBI chr 3:77,952,589...77,993,513
Ensembl chr 3:77,952,540...77,993,456

G

CDP-L-ribitol pyrophosphorylase A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRPPA mRNA

NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028

G

cytotoxic and regulatory T cell molecule

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA

NCBI chr 8:41,340,117...41,377,381
Ensembl chr 8:41,340,837...41,377,343

G

cryptochrome circadian regulator 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CRY1 mRNA

NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091

G

cysteine and serine rich nuclear protein 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA

NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:131,594,232...131,610,075

G

catenin alpha 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CTNNA3 mRNA

NCBI chr20:23,614,469...25,200,026
Ensembl chr20:23,623,560...25,199,978

G

catenin delta 2

increases expression

Cacodylic Acid results in increased expression of CTNND2 mRNA

NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764

G

cathepsin G

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of CTSG mRNA

NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353

G

cathepsin H

decreases expression

Cacodylic Acid results in decreased expression of CTSH mRNA

NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824

G

C-X-C motif chemokine ligand 10

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL10 mRNA

NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975

G

C-X-C motif chemokine ligand 17

decreases expression

Cacodylic Acid results in decreased expression of CXCL17 mRNA

NCBI chr 1:80,984,751...80,996,842
Ensembl chr 1:80,984,964...80,996,726

G

C-X-C motif chemokine ligand 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA

NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435

G

cytochrome b-245 beta chain

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA

NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586

G

cytochrome b reductase 1

decreases expression

Cacodylic Acid results in decreased expression of CYBRD1 mRNA

NCBI chr 3:55,934,874...55,962,132
Ensembl chr 3:55,934,874...55,962,108

G

cytoplasmic FMR1 interacting protein 2

decreases expression

Cacodylic Acid results in decreased expression of CYFIP2 mRNA

NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases expression
decreases expression

AHR mutant form inhibits the reaction [Cacodylic Acid results in increased expression of CYP1A1 protein]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Cacodylic Acid results in increased expression of and results in increased activity of CYP1A1 protein
Cacodylic Acid results in increased expression of CYP1A1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CYP1A1 mRNA; Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 protein]
Cacodylic Acid results in decreased expression of CYP1A1 mRNA

PMID:24161444 PMID:28134025 PMID:34876320 PMID:37567419

NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases expression

Cacodylic Acid results in increased expression of CYP1A2 mRNA

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 1, subfamily b, polypeptide 1

decreases expression

Cacodylic Acid results in decreased expression of CYP1B1 mRNA

NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917

G

cytochrome P450, family 2, subfamily b, polypeptide 1

multiple interactions
increases expression

[Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein
Cacodylic Acid results in increased expression of CYP2B1 mRNA

PMID:12115560 PMID:17481689

NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052

G

cytochrome P450, family 2, subfamily b, polypeptide 2

multiple interactions

[Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA

NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566

G

cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1

increases expression

Cacodylic Acid results in increased expression of CYP3A23-3A1 mRNA

NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
Ensembl chr12:9,254,475...9,285,030

G

cytochrome P450, family 4, subfamily f, polypeptide 18

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA

NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940

G

cytochrome P450 family 7 subfamily B member 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of CYP7B1 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CYP7B1 mRNA]

NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698

G

DAB adaptor protein 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DAB1 mRNA

NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552

G

D-box binding PAR bZIP transcription factor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745

G

doublecortin-like kinase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DCLK3 mRNA

NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:111,401,358...111,453,999

G

damage specific DNA binding protein 2

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of DDB2 mRNA

NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631

G

DNA-damage inducible transcript 3

increases expression

Cacodylic Acid results in increased expression of DDIT3 mRNA

NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201

G

DEAD box helicase 3, Y-linked

increases expression

Cacodylic Acid results in increased expression of DDX3Y mRNA

NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,116,309...1,135,706

G

DEF6 guanine nucleotide exchange factor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DEF6 mRNA

NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,268,601...6,289,961

G

defensin alpha 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DEFA21 mRNA

NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836

G

DEP domain containing 1

increases expression

Cacodylic Acid results in increased expression of DEPDC1 mRNA

NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951

G

diacylglycerol kinase, beta

decreases expression

Cacodylic Acid results in decreased expression of DGKB mRNA

NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:54,641,614...55,397,043

G

7-dehydrocholesterol reductase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DHCR7 mRNA

NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055

G

dehydrogenase/reductase 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA

NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241

G

DIRAS family GTPase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA

NCBI chr17:12,730,040...12,761,511
Ensembl chr17:12,725,149...12,761,663

G

dickkopf WNT signaling pathway inhibitor 2

decreases expression

Cacodylic Acid results in decreased expression of DKK2 mRNA

NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:220,568,338...220,660,225

G

dynein, axonemal, heavy chain 10

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAH10 mRNA

NCBI chr12:31,823,451...31,946,857
Ensembl chr12:31,822,733...32,007,069

G

dynein, axonemal, heavy chain 9

decreases expression

Cacodylic Acid results in decreased expression of DNAH9 mRNA

NCBI chr10:50,496,174...50,864,909
Ensembl chr10:50,497,688...50,864,949

G

dynein axonemal intermediate chain 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAI4 mRNA

NCBI chr 5:117,787,398...117,876,216
Ensembl chr 5:117,788,464...117,876,127

G

DnaJ heat shock protein family (Hsp40) member B13

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB13 mRNA

NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:154,848,594...154,862,963

G

DnaJ heat shock protein family (Hsp40) member B3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB3 mRNA

NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:88,795,488...88,796,560

G

deoxyribonuclease 1 like 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNASE1L2 mRNA

NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,471,479...13,473,763

G

deoxyribonuclease 1L3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNASE1L3 mRNA

NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317

G

dedicator of cytokinesis 10

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK10 mRNA

NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:81,843,604...82,101,525

G

dedicator of cytokinesis 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK2 mRNA

NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808

G

docking protein 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOK3 mRNA

NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188

G

dopamine receptor D3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DRD3 mRNA

NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596

G

dual oxidase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOX2 mRNA

NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902

G

dual oxidase maturation factor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA1 mRNA

NCBI chr 3:109,249,815...109,260,511
Ensembl chr 3:109,249,923...109,260,499

G

dual oxidase maturation factor 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA2 mRNA

NCBI chr 3:109,245,337...109,249,055
Ensembl chr 3:109,245,476...109,248,968

G

dual specificity phosphatase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP1 mRNA

NCBI chr10:16,680,478...16,683,275

G

dual specificity phosphatase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA

NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499

G

dual specificity phosphatase 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP6 mRNA

NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185

G

ELL associated factor 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EAF2 mRNA

NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610

G

epithelial cell transforming 2

increases expression

Cacodylic Acid results in increased expression of ECT2 mRNA

NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911

G

endothelin 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EDN1 mRNA

NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885

G

eukaryotic translation elongation factor 1 alpha 1

decreases expression

Cacodylic Acid results in decreased expression of EEF1A1 mRNA

NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839

G

ephrin A3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EFNA3 mRNA

NCBI chr 2:174,729,192...174,738,111
Ensembl chr 2:174,729,764...174,738,736

G

epidermal growth factor receptor

increases expression

Cacodylic Acid results in increased expression of EGFR mRNA

NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382

G

early growth response 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of EGR1 mRNA
[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of EGR1 mRNA; [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of EGR1 mRNA

PMID:15345372 PMID:23192986 PMID:28793237

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

early growth response 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA

NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627

G

EH-domain containing 3

increases expression

Cacodylic Acid results in increased expression of EHD3 mRNA

NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236

G

euchromatic histone lysine methyltransferase 2

increases expression

Cacodylic Acid results in increased expression of EHMT2 mRNA

NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547

G

eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked

increases expression

Cacodylic Acid results in increased expression of EIF2S3Y mRNA

NCBI chr Y:869,654...889,341
Ensembl chr Y:869,689...889,340

G

extracellular leucine-rich repeat and fibronectin type III domain containing 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ELFN2 mRNA

NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:110,225,919...110,272,433

G

embigin

increases expression

Cacodylic Acid results in increased expression of EMB mRNA

NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050

G

endonuclease, poly(U)-specific

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ENDOU mRNA

NCBI chr 7:128,844,872...128,866,572
Ensembl chr 7:128,844,862...128,866,596

G

enolase 2

decreases expression

Cacodylic Acid results in decreased expression of ENO2 mRNA

NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

decreases expression

Cacodylic Acid results in decreased expression of ENPP2 mRNA

NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827

G

eomesodermin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EOMES mRNA

NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316

G

EPM2A glucan phosphatase, laforin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EPM2A mRNA

NCBI chr 1:5,727,111...5,845,338
Ensembl chr 1:5,727,066...5,920,555

G

erb-b2 receptor tyrosine kinase 2

multiple interactions

Cacodylic Acid results in increased expression of and results in increased phosphorylation of ERBB2 protein

NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078

G

epiregulin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EREG mRNA

NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062

G

endogenous retrovirus group FRD member 1, envelope

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA

NCBI chr12:22,151,211...22,158,264
Ensembl chr12:22,151,211...22,158,264

G

estrogen receptor 1

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of ESR1 mRNA

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

ethanolamine kinase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA

NCBI chr13:44,811,012...44,829,052
Ensembl chr13:44,811,015...44,829,037

G

ETS proto-oncogene 1, transcription factor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ETS1 mRNA

NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010

G

exophilin 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EXPH5 mRNA

NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169

G

fatty acid binding protein 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP1 mRNA

NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788

G

fatty acid binding protein 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA

NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718

G

family with sequence similarity 151, member A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM151A mRNA

NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555

G

FAM161 centrosomal protein B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM161B mRNA

NCBI chr 6:103,990,603...104,007,754
Ensembl chr 6:103,992,170...104,018,776

G

family with sequence similarity 169, member B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM169B mRNA

NCBI chr 1:121,878,670...121,968,272
Ensembl chr 1:121,878,713...121,958,470

G

family with sequence similarity 89, member A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM89A mRNA

NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631

G

Fas cell surface death receptor

decreases expression

Cacodylic Acid results in decreased expression of FAS mRNA

NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591

G

Fas ligand

increases expression
decreases expression

Cacodylic Acid results in increased expression of FASLG mRNA
Cacodylic Acid results in decreased expression of FASL mRNA

PMID:15345372 PMID:17481689

NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215

G

fibulin 1

decreases expression

Cacodylic Acid results in decreased expression of FBLN1 mRNA

NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075

G

fibulin 5

decreases expression

Cacodylic Acid results in decreased expression of FBLN5 mRNA

NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755

G

fibrillin 1

decreases expression

Cacodylic Acid results in decreased expression of FBN1 mRNA

NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889

G

fructose-bisphosphatase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA

NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071

G

F-box and leucine-rich repeat protein 22

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXL22 mRNA

NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685

G

F-box protein 24

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA

NCBI chr12:19,072,668...19,083,067
Ensembl chr12:19,072,716...19,083,067

G

Fc epsilon receptor II

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCER2A mRNA

NCBI chr12:1,742,809...1,754,476
Ensembl chr12:1,742,815...1,754,476

G

Fc gamma receptor 2B

decreases expression

Cacodylic Acid results in decreased expression of FCGR2B mRNA

NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778

G

Fc receptor-like A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA

NCBI chr13:83,160,453...83,170,170
Ensembl chr13:83,160,398...83,170,762

G

farnesyl diphosphate farnesyl transferase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDFT1 mRNA

NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287

G

farnesyl diphosphate synthase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDPS mRNA

NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776

G

fer-1-like family member 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FER1L5 mRNA

NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425

G

FEV transcription factor, ETS family member

decreases expression

Cacodylic Acid results in decreased expression of FEV mRNA

NCBI chr 9:76,439,164...76,443,603
Ensembl chr 9:76,439,172...76,443,065

G

free fatty acid receptor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FFAR1 mRNA

NCBI chr 1:86,111,368...86,112,272
Ensembl chr 1:86,111,368...86,112,272

G

fibroblast growth factor 11

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FGF11 mRNA

NCBI chr10:54,516,508...54,522,067
Ensembl chr10:54,517,077...54,522,062

G

fibroblast growth factor 2

increases expression

Cacodylic Acid results in increased expression of FGF2 mRNA

NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221

G

fibroblast growth factor 23

decreases expression

Cacodylic Acid results in decreased expression of FGF23 mRNA

NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821

G

fibroblast growth factor 9

increases expression

Cacodylic Acid results in increased expression of FGF9 mRNA

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309

G

fibroblast growth factor binding protein 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGFBP3 mRNA

NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:234,644,019...234,646,547

G

fibrinogen-like 2

decreases expression

Cacodylic Acid results in decreased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

FGR proto-oncogene, Src family tyrosine kinase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGR mRNA

NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326

G

fibrinogen C domain containing 1

decreases expression

Cacodylic Acid results in decreased expression of FIBCD1 mRNA

NCBI chr 3:15,092,682...15,126,371
Ensembl chr 3:15,092,681...15,126,399

G

FKBP prolyl isomerase 5

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA

NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674

G

flagellum associated containing coiled-coil domains 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLACC1 mRNA

NCBI chr 9:60,315,581...60,343,692
Ensembl chr 9:60,315,582...60,343,648

G

filaggrin

increases expression

Cacodylic Acid results in increased expression of FLG mRNA

NCBI chr 2:178,884,793...178,912,986

G

Fli-1 proto-oncogene, ETS transcription factor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLI1 mRNA

NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:30,832,753...30,950,433

G

filamin C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLNC mRNA

NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844

G

Fms related receptor tyrosine kinase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLT3 mRNA

NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474

G

fibronectin type III domain containing 10

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FNDC10 mRNA

NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FOS mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FOS mRNA

PMID:23192986 PMID:34876320

NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036

G

forkhead box Q1

increases expression

Cacodylic Acid results in increased expression of FOXQ1 mRNA

NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377

G

formyl peptide receptor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FPR1 mRNA

NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:58,747,246...58,756,559

G

fascin actin-bundling protein 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FSCN1 mRNA

NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211

G

ferritin heavy chain 1

increases expression

Cacodylic Acid results in increased expression of FTH1 mRNA

NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424

G

ferritin light chain 1

increases expression

Cacodylic Acid results in increased expression of FTL1 mRNA

NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725
Ensembl chr10:95,936,387...95,939,725

G

fucosyltransferase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FUT1 mRNA

NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616

G

fucosyltransferase 11

decreases expression

Cacodylic Acid results in decreased expression of FUT11 mRNA

NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356

G

growth arrest and DNA-damage-inducible, alpha

increases expression
multiple interactions

Cacodylic Acid results in increased expression of GADD45A mRNA
Cacodylic Acid analog results in increased expression of GADD45A protein
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GADD45A mRNA

PMID:16122865 PMID:23994116 PMID:34876320

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

cyclin G associated kinase

increases expression

Cacodylic Acid results in increased expression of GAK mRNA

NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398

G

growth arrest specific 6

decreases expression

Cacodylic Acid results in decreased expression of GAS6 mRNA

NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904

G

golgi associated kinase 1B

decreases expression

Cacodylic Acid results in decreased expression of FAM198B mRNA

NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477

G

GATA binding protein 5

decreases expression

Cacodylic Acid results in decreased expression of GATA5 mRNA

NCBI chr 3:167,418,563...167,426,751
Ensembl chr 3:167,418,565...167,426,751

G

guanylate binding protein 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA

NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879

G

guanylate binding protein family member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062
Ensembl chr14:4,730,453...4,839,062

G

GTP cyclohydrolase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GCH1 mRNA

NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698

G

glutamate-cysteine ligase, catalytic subunit

multiple interactions

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GCLC protein

NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544

G

glutamate cysteine ligase, modifier subunit

multiple interactions

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GCLM protein

NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535

G

germinal center-associated, signaling and motility

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GCSAM mRNA

NCBI chr11:55,195,757...55,207,011
Ensembl chr11:55,196,712...55,206,992

G

growth differentiation factor 15

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA

NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055

G

GDP dissociation inhibitor 2

increases expression

Cacodylic Acid results in increased expression of GDI2 mRNA

NCBI chr17:66,649,616...66,676,299
Ensembl chr17:66,649,619...66,676,366

G

GDNF family receptor alpha 2

decreases expression

Cacodylic Acid results in decreased expression of GFRA2 mRNA

NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714

G

GTPase, IMAP family member 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP5 mRNA

NCBI chr 4:77,693,417...77,701,025
Ensembl chr 4:77,687,564...77,703,086

G

GTPase, IMAP family member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA

NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:77,652,610...77,659,116

G

GTPase, IMAP family member 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP8 mRNA

NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:77,600,186...77,611,590

G

gap junction protein, beta 1

increases expression

Cacodylic Acid results in increased expression of GJB1 mRNA

NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925

G

gap junction protein, beta 4

increases expression

Cacodylic Acid results in increased expression of GJB4 mRNA

NCBI chr 5:139,675,776...139,679,551
Ensembl chr 5:139,675,780...139,679,667

G

GLI family zinc finger 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA

NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251

G

glycine receptor, beta

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GLRB mRNA

NCBI chr 2:166,134,616...166,207,498
Ensembl chr 2:166,134,626...166,207,489

G

glutaredoxin

increases expression

Cacodylic Acid results in increased expression of GLRX mRNA

NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680

G

glutaminase 2

increases expression

Cacodylic Acid results in increased expression of GLS2 mRNA

NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426

G

G protein subunit alpha 15

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNA15 mRNA

NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508

G

G protein subunit alpha transducin 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA

NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671

G

G protein subunit gamma 5

increases expression

Cacodylic Acid results in increased expression of GNG5 mRNA

NCBI chr 2:235,394,680...235,403,177
Ensembl chr 1:77,292,043...77,292,513

G

glycoprotein Ib platelet subunit beta

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of GP1BB mRNA

NCBI chr11:82,378,216...82,379,393
Ensembl chr11:82,378,199...82,379,392

G

glypican 3

decreases expression

Cacodylic Acid results in decreased expression of GPC3 mRNA

NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798

G

G protein-coupled receptor 132

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR132 mRNA

NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:131,924,160...131,942,168

G

G protein-coupled receptor 157

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA

NCBI chr 5:160,550,703...160,566,432
Ensembl chr 5:160,550,713...160,566,432

G

G protein-coupled receptor 17

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPR17 mRNA

NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966

G

G protein-coupled receptor 174

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR174 mRNA

NCBI chr X:72,355,452...72,396,146
Ensembl chr X:72,355,033...72,397,658

G

G protein-coupled receptor 179

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR179 mRNA

NCBI chr10:82,324,568...82,340,448
Ensembl chr10:82,337,771...82,340,448

G

G protein-coupled receptor 18

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA

NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470

G

G protein-coupled receptor 183

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA

NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559

G

G protein-coupled receptor 34

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR34 mRNA

NCBI chr X:9,104,829...9,113,796
Ensembl chr X:9,104,565...9,148,601

G

glutathione peroxidase 1

increases expression

Cacodylic Acid results in increased expression of GPX1 mRNA

NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024

G

glutathione peroxidase 2

increases expression

Cacodylic Acid results in increased expression of GPX2 mRNA

NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877

G

glutathione peroxidase 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPX7 mRNA

NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004

G

GRAM domain containing 2A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAMD2A mRNA

NCBI chr 8:60,079,744...60,117,788
Ensembl chr 8:60,080,338...60,115,842

G

GRB2-related adaptor protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAP mRNA

NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056

G

granulin precursor

increases expression

Cacodylic Acid results in increased expression of GRN mRNA

NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775

G

GrpE-like 1, mitochondrial

increases expression

Cacodylic Acid results in increased expression of GRPEL1 mRNA

NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200

G

glutathione-disulfide reductase

multiple interactions

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GSR protein

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661

G

glutathione S-transferase alpha 2

decreases expression
increases expression

Cacodylic Acid results in decreased expression of GSTA2 mRNA; Cacodylic Acid results in decreased expression of GSTA2 protein
Cacodylic Acid results in increased expression of GSTA2 mRNA

PMID:16436460 PMID:17481689

NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798

G

glutathione S-transferase alpha 4

increases expression

Cacodylic Acid results in increased expression of GSTA4 mRNA

NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182

G

glutathione S-transferase mu 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of GSTM1 mRNA; Cacodylic Acid results in increased expression of GSTM1 protein
[GSTM1 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid

PMID:16436460 PMID:32650499

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

glutathione S-transferase mu 2

increases expression

Cacodylic Acid results in increased expression of GSTM5 mRNA

NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961

G

glutathione S-transferase omega 2

multiple interactions

[GSTO2 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid

NCBI chr 1:246,731,314...246,757,592
Ensembl chr 1:246,732,089...246,753,866

G

glutathione S-transferase pi 1

increases expression
decreases expression

Cacodylic Acid results in increased expression of GSTP1 mRNA
Cacodylic Acid results in decreased expression of GSTP1 mRNA

PMID:16122865 PMID:17481689 PMID:32052077

NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226

G

glutathione S-transferase theta 1

affects metabolic processing
affects response to substance
multiple interactions

GSTT1 protein affects the metabolism of Cacodylic Acid
GSTT1 gene affects the susceptibility to Cacodylic Acid
[GSTT1 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid

PMID:17431481 PMID:32650499

NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585

G

general transcription factor IIF subunit 2

increases expression

Cacodylic Acid results in increased expression of GTF2F2 mRNA

NCBI chr15:51,206,027...51,327,166
Ensembl chr15:51,206,031...51,327,253

G

guanylate cyclase activator 1B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GUCA1B mRNA

NCBI chr 9:13,599,619...13,607,455
Ensembl chr 9:13,599,619...13,607,455

G

glucoside xylosyltransferase 2

decreases expression

Cacodylic Acid results in decreased expression of GXYLT2 mRNA

NCBI chr 4:133,347,230...133,449,708
Ensembl chr 4:133,347,499...133,449,454

G

granzyme K

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GZMK mRNA

NCBI chr 2:44,840,811...44,848,829
Ensembl chr 2:44,840,811...44,848,894

G

H1.0 linker histone

increases expression

Cacodylic Acid results in increased expression of H1F0 mRNA

NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694

G

3-hydroxyanthranilate 3,4-dioxygenase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HAAO mRNA

NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877

G

3-hydroxyacyl-CoA dehydratase 4

decreases expression

Cacodylic Acid results in decreased expression of HACD4 mRNA

NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338

G

hyaluronan and proteoglycan link protein 2

decreases expression

Cacodylic Acid results in decreased expression of HAPLN2 mRNA

NCBI chr 2:173,488,909...173,496,824
Ensembl chr 2:173,491,160...173,496,588

G

hematopoietic cell specific Lyn substrate 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA

NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014

G

hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCN2 mRNA

NCBI chr 7:9,969,801...9,988,839
Ensembl chr 7:9,970,368...9,988,841

G

histidine decarboxylase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HDC mRNA

NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341

G

hedgehog acyltransferase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHAT mRNA

NCBI chr13:104,024,507...104,283,580
Ensembl chr13:104,010,916...104,282,893

G

hematopoietically expressed homeobox

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHEX mRNA

NCBI chr 1:235,190,455...235,196,042
Ensembl chr 1:235,190,455...235,196,042

G

Hedgehog-interacting protein

decreases expression

Cacodylic Acid results in decreased expression of HHIP mRNA

NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528

G

HIG1 hypoxia inducible domain family, member 2A

decreases expression

Cacodylic Acid results in decreased expression of HIGD2A mRNA

NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,021,859...10,022,796

G

hexokinase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HK2 mRNA

NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS1 mRNA

NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS2 mRNA

NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130

G

heme oxygenase 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of HMOX1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of HMOX1 mRNA

PMID:15345372 PMID:23192986

NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079

G

4-hydroxy-2-oxoglutarate aldolase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HOGA1 mRNA

NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:240,857,126...240,884,568

G

homeobox A1

decreases expression

Cacodylic Acid results in decreased expression of HOXA1 mRNA

NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504

G

homeobox A2

decreases expression

Cacodylic Acid results in decreased expression of HOXA2 mRNA

NCBI chr 4:81,262,668...81,266,970
Ensembl chr 4:81,262,768...81,265,044

G

hippocalcin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HPCA mRNA

NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841

G

heparan sulfate-glucosamine 3-sulfotransferase 3B1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HS3ST3B1 mRNA

NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970

G

heat shock transcription factor 2 binding protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSF2BP mRNA

NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,562...10,121,242

G

heat shock protein family A (Hsp70) member 1A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1A mRNA

NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227

G

heat shock protein family A (Hsp70) member 1B

multiple interactions
decreases expression

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA1B mRNA]

PMID:17441966 PMID:34876320

NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
Ensembl chr20:3,856,006...3,873,240

G

heat shock protein family A (Hsp70) member 4 like

multiple interactions
decreases expression

OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA4L mRNA]

NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084

G

heat shock protein family A (Hsp70) member 5

increases expression

Cacodylic Acid results in increased expression of HSPA5 mRNA

NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891

G

heat shock protein family A (Hsp70) member 8

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of HSPA8 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA8 mRNA; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA8 mRNA]

PMID:17441966 PMID:34876320

NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259

G

heat shock protein family B (small) member 1

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of HSPB1 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPB1 mRNA]

NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743

G

heat shock protein family B (small) member 6

decreases expression

Cacodylic Acid results in decreased expression of HSPB6 mRNA

NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:85,806,146...85,809,071

G

heat shock protein family B (small) member 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSPB7 mRNA

NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266

G

heat shock protein family D (Hsp60) member 1

increases expression

Cacodylic Acid results in increased expression of HSPD1 mRNA

NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662

G

heat shock protein family E (Hsp10) member 1

increases expression

Cacodylic Acid results in increased expression of HSPE1 mRNA

NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089

G

heat shock protein family H (Hsp110) member 1

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of HSPH1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPH1 mRNA; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPH1 mRNA]

PMID:17441966 PMID:34876320

NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224

G

HtrA serine peptidase 3

decreases expression

Cacodylic Acid results in decreased expression of HTRA3 mRNA

NCBI chr14:75,068,917...75,097,315
Ensembl chr14:75,068,917...75,097,315

G

hydrogen voltage-gated channel 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HVCN1 mRNA

NCBI chr12:34,341,673...34,370,010
Ensembl chr12:34,335,190...34,370,141

G

intercellular adhesion molecule 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICAM1 mRNA

NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438

G

intercellular adhesion molecule 5

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA

NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588

G

inducible T-cell co-stimulator

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICOS mRNA

NCBI chr 9:62,368,075...62,406,900
Ensembl chr 9:62,383,832...62,405,672

G

insulin-like growth factor 1

decreases expression

Cacodylic Acid results in decreased expression of IGF1 mRNA

NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor 1 receptor

increases expression

Cacodylic Acid results in increased expression of IGF1R mRNA

NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777

G

insulin-like growth factor binding protein 1

increases expression

Cacodylic Acid results in increased expression of IGFBP1 mRNA

NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482

G

insulin-like growth factor binding protein 4

decreases expression

Cacodylic Acid results in decreased expression of IGFBP4 mRNA

NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225

G

immunoglobulin heavy chain like 16

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of IGHV4-1 mRNA

NCBI chr 6:134,212,480...134,234,464

G

immunoglobulin kappa variable like, pseudogene 13

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA

NCBI chr 4:96,968,574...96,969,477

G

immunoglobulin superfamily, member 10

decreases expression

Cacodylic Acid results in decreased expression of IGSF10 mRNA

NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773

G

inhibitor of nuclear factor kappa B kinase subunit beta

increases expression

Cacodylic Acid results in increased expression of IKBKB protein

NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250

G

IKAROS family zinc finger 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IKZF1 mRNA

NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416

G

interleukin 10 receptor subunit alpha

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL10RA mRNA

NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061

G

interleukin 13 receptor subunit alpha 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA

NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381

G

interleukin 17A

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of IL17A mRNA

NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889

G

interleukin 18 receptor accessory protein

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of IL18RAP mRNA

NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959

G

interleukin 1 beta

increases secretion

Cacodylic Acid results in increased secretion of IL1B protein

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 20 receptor subunit beta

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL20RB mRNA

NCBI chr 8:100,979,085...101,010,829
Ensembl chr 8:100,980,383...101,009,942

G

interleukin 21 receptor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA

NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522

G

interleukin 22 receptor subunit alpha 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA

NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:14,364,489...14,377,844

G

interleukin 24

increases expression

Cacodylic Acid results in increased expression of IL24 mRNA

NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487

G

interleukin 27 receptor subunit alpha

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA

NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938

G

interleukin 33

decreases expression

Cacodylic Acid results in decreased expression of IL33 mRNA

NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373

G

interleukin 36, beta

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL36B mRNA

NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:7,021,973...7,031,619

G

interleukin 5 receptor subunit alpha

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL5RA mRNA

NCBI chr 4:139,630,652...139,664,593
Ensembl chr 4:139,632,066...139,668,544

G

interleukin 7 receptor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL7R mRNA

NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757

G

interleukin 9 receptor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL9R mRNA

NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,431,706...15,441,990

G

inhibin subunit beta E

decreases expression

Cacodylic Acid results in decreased expression of INHBE mRNA

NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172

G

insulin induced gene 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA

NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952

G

interferon regulatory factor 1

increases expression

Cacodylic Acid results in increased expression of IRF1 mRNA

NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166

G

interferon regulatory factor 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IRF4 mRNA

NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070

G

interferon regulatory factor 5

decreases expression

Cacodylic Acid results in decreased expression of IRF5 mRNA

NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267

G

integrin subunit alpha 10

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA

NCBI chr 2:184,182,869...184,202,172
Ensembl chr 2:184,182,869...184,202,172

G

integrin subunit alpha 11

decreases expression

Cacodylic Acid results in decreased expression of ITGA11 mRNA

NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:63,146,001...63,254,407

G

integrin subunit alpha 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGA8 mRNA

NCBI chr17:75,304,004...75,501,510
Ensembl chr17:75,304,008...75,501,510

G

integrin subunit alpha L

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGAL mRNA

NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732

G

integrin subunit beta 1

decreases expression
increases expression

Cacodylic Acid results in decreased expression of ITGB1 mRNA
Cacodylic Acid results in increased expression of ITGB1 mRNA

PMID:16122865 PMID:17720352

NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195

G

integrin subunit beta 6

decreases expression

Cacodylic Acid results in decreased expression of ITGB6 mRNA

NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671

G

integrin subunit beta 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGB8 mRNA

NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476

G

inter-alpha trypsin inhibitor, heavy chain 3

increases expression

Cacodylic Acid results in increased expression of ITIH3 mRNA

NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924

G

integral membrane protein 2A

decreases expression

Cacodylic Acid results in decreased expression of ITM2A mRNA

NCBI chr X:72,486,383...72,492,344
Ensembl chr X:72,486,381...72,492,363

G

ITPRIP like 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITPRIPL2 mRNA

NCBI chr 1:172,801,152...172,803,047
Ensembl chr 1:172,796,849...172,802,950

G

IZUMO1 receptor, JUNO

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IZUMO1R mRNA

NCBI chr 8:11,744,384...11,748,131
Ensembl chr 8:11,725,863...11,748,465

G

jagged canonical Notch ligand 1

decreases expression

Cacodylic Acid results in decreased expression of JAG1 mRNA

NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209

G

Janus kinase 2

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of JAK2 mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of JAK2 protein

PMID:17720352 PMID:32890875

NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189

G

Jun proto-oncogene, AP-1 transcription factor subunit

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of JUN mRNA

NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656

G

potassium voltage-gated channel subfamily D member 3

decreases expression

Cacodylic Acid results in decreased expression of KCND3 mRNA

NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345

G

potassium voltage-gated channel modifier subfamily G member 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNG1 mRNA

NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:156,973,156...156,992,635

G

potassium voltage-gated channel interacting protein 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA

NCBI chr14:61,380,699...62,531,399
Ensembl chr14:61,381,076...62,530,144

G

potassium inwardly-rectifying channel, subfamily J, member 13

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNJ13 mRNA

NCBI chr 9:88,063,003...88,071,112
Ensembl chr 9:88,063,003...88,071,112

G

potassium two pore domain channel subfamily K member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNK6 mRNA

NCBI chr 1:84,525,613...84,533,948
Ensembl chr 1:84,525,590...84,534,677

G

potassium calcium-activated channel subfamily M regulatory beta subunit 1

decreases expression

Cacodylic Acid results in decreased expression of KCNMB1 mRNA

NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798

G

lysine demethylase 5D

increases expression

Cacodylic Acid results in increased expression of KDM5D mRNA

NCBI chr Y:527,069...624,019
Ensembl chr Y:530,401...624,018

G

kinesin family member 11

increases expression

Cacodylic Acid results in increased expression of KIF11 mRNA

NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766

G

kinesin family member 1B

increases expression

Cacodylic Acid results in increased expression of KIF1B mRNA

NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778

G

kinesin family member 20A

increases expression

Cacodylic Acid results in increased expression of KIF20A mRNA

NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780

G

kinesin family member 20B

increases expression

Cacodylic Acid results in increased expression of KIF20B mRNA

NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787

G

kinesin family member 4A

increases expression

Cacodylic Acid results in increased expression of KIF4A mRNA

NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139

G

kelch-like family member 30

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL30 mRNA

NCBI chr 9:91,942,475...91,952,756
Ensembl chr 9:91,942,504...91,952,730

G

kelch-like family member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL6 mRNA

NCBI chr11:80,970,917...81,010,593
Ensembl chr11:80,970,917...81,009,677

G

killer cell lectin like receptor B1A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLRB1 mRNA

NCBI chr 4:161,890,577...161,904,050
Ensembl chr 4:161,890,577...161,961,675

G

kynurenine 3-monooxygenase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA

NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881

G

kinetochore scaffold 1

increases expression

Cacodylic Acid results in increased expression of KNL1 mRNA

NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915

G

karyopherin subunit beta 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of KPNB1 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of KPNB1 mRNA]

NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605

G

keratin 10

increases expression

Cacodylic Acid results in increased expression of KRT10 mRNA

NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701

G

keratin 12

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA

NCBI chr10:84,370,803...84,378,103
Ensembl chr10:84,370,883...84,378,045

G

keratin 13

increases expression

Cacodylic Acid results in increased expression of KRT13 mRNA

NCBI chr10:85,051,887...85,056,099
Ensembl chr10:85,051,889...85,056,084

G

keratin 14

increases expression

Cacodylic Acid results in increased expression of KRT14 mRNA; Cacodylic Acid results in increased expression of KRT14 protein

PMID:33211169 PMID:37567419

NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799

G

keratin 15

increases expression

Cacodylic Acid results in increased expression of KRT15 mRNA

NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799

G

keratin 17

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA

NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392

G

keratin 18

decreases expression
increases expression

Cacodylic Acid results in decreased expression of KRT18 mRNA
Cacodylic Acid results in increased expression of KRT18 mRNA

PMID:17481689 PMID:32052077

NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166

G

keratin 20

decreases expression

Cacodylic Acid results in decreased expression of KRT20 mRNA

NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107

G

keratin 25

increases expression

Cacodylic Acid results in increased expression of KRT25 mRNA

NCBI chr10:84,267,399...84,275,025
Ensembl chr10:84,267,399...84,274,965

G

keratin 27

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT27 mRNA

NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,298,508...84,303,967

G

keratin 4

increases expression

Cacodylic Acid results in increased expression of KRT4 mRNA

NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:133,046,515...133,052,019

G

keratin 5

increases expression

Cacodylic Acid results in increased expression of KRT5 mRNA

NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850

G

keratin 8

increases expression

Cacodylic Acid results in increased expression of KRT8 mRNA; Cacodylic Acid results in increased expression of KRT8 protein

NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728

G

keratin associated protein 14

increases expression

Cacodylic Acid results in increased expression of KRTAP14 mRNA

NCBI chr11:28,126,660...28,127,502
Ensembl chr11:28,126,660...28,127,502

G

keratin associated protein 8-1

increases expression

Cacodylic Acid results in increased expression of KRTAP8-1 mRNA

NCBI chr11:28,717,798...28,718,355
Ensembl chr11:28,718,125...28,718,310

G

keratinocyte associated protein 2

decreases expression

Cacodylic Acid results in decreased expression of KRTCAP2 mRNA

NCBI chr 2:174,654,409...174,658,405
Ensembl chr 2:174,654,219...174,658,405

G

L3MBTL histone methyl-lysine binding protein 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA

NCBI chr 1:18,988,763...19,089,247
Ensembl chr 1:18,990,618...19,089,263

G

ladinin 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAD1 mRNA

NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967

G

leucyl-tRNA synthetase 2, mitochondrial

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LARS2 mRNA

NCBI chr 8:123,010,271...123,106,395
Ensembl chr 8:123,010,293...123,106,395

G

lymphocyte transmembrane adaptor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAX1 mRNA

NCBI chr13:45,134,825...45,145,381
Ensembl chr13:45,134,834...45,145,381

G

lipopolysaccharide binding protein

decreases expression

Cacodylic Acid results in decreased expression of LBP mRNA

NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586

G

lymphocyte cytosolic protein 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LCP1 mRNA

NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680

G

low density lipoprotein receptor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LDLR mRNA

NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580

G

lymphoid enhancer binding factor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LEF1 mRNA

NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794

G

galectin 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LGALS2 mRNA

NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802

G

galectin 3

increases expression

Cacodylic Acid results in increased expression of LGALS3 mRNA

NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025

G

galectin 8

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of LGALS8 mRNA

NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764

G

leucine rich repeat containing G protein coupled receptor 5

decreases expression

Cacodylic Acid results in decreased expression of LGR5 mRNA

NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446

G

LHFPL tetraspan subfamily member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA

NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950

G

lipase C, hepatic type

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LIPC mRNA

NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464

G

lectin, mannose-binding, 1

increases expression

Cacodylic Acid results in increased expression of LMAN1 mRNA

NCBI chr18:59,508,996...59,530,873
Ensembl chr18:59,508,996...59,530,851

G

small proline-rich protein 2I-like

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2H mRNA

NCBI chr 2:177,815,964...177,816,236
Ensembl chr 2:177,815,964...177,816,236

G

lysophosphatidylcholine acyltransferase 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LPCAT4 mRNA

NCBI chr 3:99,044,729...99,052,963
Ensembl chr 3:99,044,729...99,052,875

G

lipoprotein lipase

decreases expression

Cacodylic Acid results in decreased expression of LPL mRNA

PMID:23221991 PMID:37567419

NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249

G

leupaxin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA

NCBI chr 1:209,928,297...209,963,085
Ensembl chr 1:209,929,202...209,963,084

G

lecithin retinol acyltransferase

decreases expression

Cacodylic Acid results in decreased expression of LRAT mRNA

NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619

G

leucine rich repeat containing 31

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA

NCBI chr 2:112,702,844...112,725,431
Ensembl chr 2:112,700,136...112,724,322

G

leucine rich repeat containing 55

decreases expression

Cacodylic Acid results in decreased expression of LRRC55 mRNA

NCBI chr 3:70,269,908...70,280,651
Ensembl chr 3:70,265,936...70,278,639

G

leucine-rich repeat kinase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRK2 mRNA

NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703

G

leucine rich repeat neuronal 4

decreases expression

Cacodylic Acid results in decreased expression of LRRN4 mRNA

NCBI chr 3:120,138,093...120,150,877
Ensembl chr 3:120,139,410...120,150,831

G

lanosterol synthase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LSS mRNA

NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762

G

lymphotoxin alpha

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTA mRNA

NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859

G

lymphotoxin beta

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA

NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381

G

leukotriene B4 receptor 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB4R2 mRNA

NCBI chr15:29,258,712...29,260,531
Ensembl chr15:29,259,240...29,260,316

G

lumican

decreases expression

Cacodylic Acid results in decreased expression of LUM mRNA

NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793

G

lymphocyte antigen 6 family member D

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA

NCBI chr 7:106,643,225...106,644,733
Ensembl chr 7:106,643,232...106,644,733

G

lymphocyte antigen 6 family member G6C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA

NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,753,632...3,758,867

G

lymphocyte antigen 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY9 mRNA

NCBI chr13:84,079,345...84,100,783
Ensembl chr13:84,079,458...84,100,823

G

LYL1, basic helix-loop-helix family member

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LYL1 mRNA

NCBI chr19:23,452,140...23,455,007
Ensembl chr19:23,452,140...23,455,007

G

Ly6/Plaur domain containing 3

increases expression

Cacodylic Acid results in increased expression of LYPD3 mRNA

NCBI chr 1:80,226,449...80,230,901
Ensembl chr 1:80,226,449...80,230,901

G

mal, T-cell differentiation protein-like

increases expression

Cacodylic Acid results in increased expression of MALL mRNA

NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785

G

microtubule-associated protein 1B

decreases expression

Cacodylic Acid results in decreased expression of MAP1B mRNA

NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317

G

mitogen activated protein kinase kinase kinase 12

decreases expression

Cacodylic Acid results in decreased expression of MAP3K12 mRNA

NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:133,630,835...133,640,789

G

mitogen-activated protein kinase kinase kinase 14

increases expression

Cacodylic Acid results in increased expression of MAP3K14 mRNA

NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523

G

mitogen-activated protein kinase kinase kinase 19

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K19 mRNA

NCBI chr13:39,300,150...39,343,502
Ensembl chr13:39,300,163...39,343,767

G

mitogen-activated protein kinase kinase kinase 5

increases expression

Cacodylic Acid results in increased expression of MAP3K5 mRNA

NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800

G

mitogen-activated protein kinase kinase kinase 6

decreases expression

Cacodylic Acid results in decreased expression of MAP3K6 mRNA

NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212

G

mitogen-activated protein kinase kinase kinase 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K9 mRNA

NCBI chr 6:101,423,754...101,488,822
Ensembl chr 6:101,430,292...101,488,822

G

mitogen activated protein kinase kinase kinase kinase 1

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of MAP4K1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA

PMID:17720352 PMID:34876320

NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493

G

mitogen activated protein kinase 1

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MAPK1 mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of MAPK1 protein

PMID:23192986 PMID:32890875

NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616

G

mitogen-activated protein kinase 15

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MAPK15 mRNA

NCBI chr 7:107,694,907...107,714,640
Ensembl chr 7:107,694,964...107,714,645

G

mitogen activated protein kinase 3

multiple interactions

Cacodylic Acid results in increased expression of and results in increased phosphorylation of MAPK3 protein

NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863

G

mitogen-activated protein kinase 8

increases expression
decreases expression

Cacodylic Acid results in increased expression of MAPK8 mRNA
Cacodylic Acid results in decreased expression of MAPK8 mRNA

PMID:17441966 PMID:17481689

NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981

G

microtubule-associated protein, RP/EB family, member 2

decreases expression

Cacodylic Acid results in decreased expression of MAPRE2 mRNA

NCBI chr18:15,028,675...15,169,553
Ensembl chr18:15,029,041...15,168,044

G

MAS1 proto-oncogene, G protein-coupled receptor

decreases expression

Cacodylic Acid results in decreased expression of MAS1 mRNA

NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709

G

matrilin 2

decreases expression

Cacodylic Acid results in decreased expression of MATN2 mRNA

NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113

G

membrane-bound transcription factor peptidase, site 1

increases expression

Cacodylic Acid results in increased expression of MBTPS1 mRNA

NCBI chr19:47,561,598...47,612,769
Ensembl chr19:47,561,598...47,612,791

G

melanin-concentrating hormone receptor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MCHR1 mRNA

NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032

G

MDM2 proto-oncogene

increases expression
multiple interactions

Cacodylic Acid results in increased expression of MDM2 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA

PMID:17481689 PMID:23192986

NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915

G

myocyte enhancer factor 2C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA

NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880

G

meiosis specific with coiled-coil domain

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEIOC mRNA

NCBI chr10:87,628,807...87,646,485
Ensembl chr10:87,628,875...87,646,752

G

microfibril associated protein 2

decreases expression

Cacodylic Acid results in decreased expression of MFAP2 mRNA

NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:153,314,711...153,320,259

G

microfibril associated protein 5

decreases expression

Cacodylic Acid results in decreased expression of MFAP5 mRNA

NCBI chr 4:155,727,925...155,750,458
Ensembl chr 4:155,727,925...155,750,458

G

milk fat globule EGF and factor V/VIII domain containing

increases expression
multiple interactions

Cacodylic Acid results in increased expression of MFGE8 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MFGE8 mRNA

PMID:16122865 PMID:34876320

NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073

G

major facilitator superfamily domain containing 12

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD12 mRNA

NCBI chr 7:8,345,171...8,354,050
Ensembl chr 7:8,347,314...8,353,988

G

MFSD2 lysolipid transporter B, sphingolipid

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD2B mRNA

NCBI chr 6:27,870,182...27,883,768
Ensembl chr 6:27,870,518...27,882,159

G

microsomal glutathione S-transferase 1

increases expression

Cacodylic Acid results in increased expression of MGST1 mRNA

NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892

G

microRNA 145

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR145A mRNA

NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727

G

Mir155 host gene

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA

NCBI chr11:23,773,468...23,775,697

G

microRNA 192

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR192 mRNA

NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:203,564,946...203,565,055

G

marker of proliferation Ki-67

increases expression

Cacodylic Acid results in increased expression of MKI67 mRNA

NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762

G

mohawk homeobox

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA

NCBI chr17:55,077,073...55,156,877
Ensembl chr17:55,077,540...55,156,124

G

matrix metallopeptidase 13

increases expression
multiple interactions

Cacodylic Acid results in increased expression of MMP13 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of MMP13 mRNA]

PMID:17441966 PMID:37567419

NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239

G

matrix metallopeptidase 14

increases expression

Cacodylic Acid results in increased expression of MMP14 mRNA

NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864

G

matrix metallopeptidase 17

increases expression

Cacodylic Acid results in increased expression of MMP17 mRNA

NCBI chr12:27,074,398...27,099,317
Ensembl chr12:27,074,409...27,099,316

G

matrix metallopeptidase 9

increases expression
multiple interactions

Cacodylic Acid results in increased expression of MMP9 mRNA
Cacodylic Acid results in increased expression of MMP9 protein
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [Cacodylic Acid results in increased expression of MMP9 protein]
Cacodylic Acid results in increased expression of MMP9 mRNA; Cacodylic Acid results in increased expression of MMP9 protein

PMID:17441966 PMID:32474354

NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120

G

maestro heat-like repeat family member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH6 mRNA

NCBI chr 7:107,566,212...107,576,469
Ensembl chr 7:107,569,554...107,574,173

G

maestro heat-like repeat family member 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH7 mRNA

NCBI chr 5:121,463,826...121,509,233
Ensembl chr 5:121,463,827...121,503,755

G

membrane spanning 4-domains A1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A1 mRNA

NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512

G

membrane spanning 4-domains A18

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A18 mRNA

NCBI chr 1:207,644,858...207,662,471
Ensembl chr 1:207,645,780...207,665,793

G

mutS homolog 2

decreases expression

Cacodylic Acid results in decreased expression of MSH2 mRNA

NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938

G

misato mitochondrial distribution and morphology regulator 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MSTO1 mRNA

NCBI chr 2:174,305,945...174,310,230
Ensembl chr 2:174,301,861...174,310,216

G

metallothionein 1

increases expression

Cacodylic Acid results in increased expression of MT1A mRNA

NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049

G

metallothionein 1, pseudogene 3

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MT1E mRNA

NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135

G

metallothionein 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MT4 mRNA

NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,863,813...10,865,909

G

metastasis associated 1

increases expression

Cacodylic Acid results in increased expression of MTA1 mRNA

NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:132,178,853...132,217,641

G

5-methyltetrahydrofolate-homocysteine methyltransferase

multiple interactions

[MTR gene SNP affects the susceptibility to Arsenic] which affects the abundance of Cacodylic Acid

NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822

G

mevalonate diphosphate decarboxylase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVD mRNA

NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971

G

mevalonate kinase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVK mRNA

NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882

G

MX dynamin like GTPase 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MX1 mRNA

NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507

G

Max dimerization protein 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MXD3 mRNA

NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,301,399...9,305,157

G

MYB proto-oncogene like 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA

NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183

G

MYC proto-oncogene, bHLH transcription factor

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MYC mRNA

NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630

G

myosin IG

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA

NCBI chr14:81,386,701...81,401,843
Ensembl chr14:81,386,701...81,401,843

G

myotilin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MYOT mRNA

NCBI chr18:36,705,244...36,724,849
Ensembl chr18:36,705,314...36,724,841

G

marginal zone B and B1 cell-specific protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MZB1 mRNA

NCBI chr18:27,238,999...27,241,060
Ensembl chr18:27,239,001...27,241,094

G

N-acetylated alpha-linked acidic dipeptidase-like 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAALADL1 mRNA

NCBI chr 1:203,400,632...203,414,195
Ensembl chr 1:203,400,631...203,414,195

G

napsin A aspartic peptidase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAPSA mRNA

NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:95,064,900...95,077,094

G

NBL1, DAN family BMP antagonist

increases expression

Cacodylic Acid results in increased expression of NBL1 mRNA

NCBI chr 5:151,318,752...151,329,948
Ensembl chr 5:151,318,754...151,338,719

G

neural cell adhesion molecule 1

decreases expression

Cacodylic Acid results in decreased expression of NCAM1 mRNA

NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014

G

non-SMC condensin I complex, subunit G

increases expression

Cacodylic Acid results in increased expression of NCAPG mRNA

NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902

G

neutrophil cytosolic factor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCF1 mRNA

NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646

G

noncompact myelin associated protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCMAP mRNA

NCBI chr 5:147,608,042...147,623,266
Ensembl chr 5:147,610,677...147,618,775

G

N-myc downstream regulated 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDRG1 mRNA

NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880

G

N-deacetylase and N-sulfotransferase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDST3 mRNA

NCBI chr 2:211,702,728...211,868,159
Ensembl chr 2:211,704,898...211,854,584

G

nebulin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NEB mRNA

NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574

G

nectin cell adhesion molecule 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NECTIN1 mRNA

NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787

G

neogenin 1

increases expression

Cacodylic Acid results in increased expression of NEO1 mRNA

NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348

G

NFE2 like bZIP transcription factor 2

multiple interactions

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein; [Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of NFE2L2 protein; Cacodylic Acid results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 mutant form inhibits the reaction [Cacodylic Acid results in increased expression of NQO1 protein]

PMID:24161444 PMID:33434570

NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737

G

nuclear factor I/A

increases expression

Cacodylic Acid results in increased expression of NFIA mRNA

NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885

G

nuclear factor I/C

increases expression

Cacodylic Acid results in increased expression of NFIC mRNA

NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936

G

nuclear factor, interleukin 3 regulated

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858

G

nuclear factor kappa B subunit 1

multiple interactions
increases expression

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of NFKB1 mRNA
Cacodylic Acid results in increased expression of and affects the localization of NFKB1 protein
Cacodylic Acid results in increased expression of NFKB1 mRNA

PMID:23192986 PMID:26617437

NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404

G

niban apoptosis regulator 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NIBAN3 mRNA

NCBI chr16:18,307,122...18,318,589
Ensembl chr16:18,307,221...18,318,585

G

ninjurin 1

increases expression

Cacodylic Acid results in increased expression of NINJ1 mRNA

NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704

G

NIPA-like domain containing 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NIPAL4 mRNA

NCBI chr10:30,583,926...30,600,640
Ensembl chr10:30,583,926...30,600,640

G

NLR family, pyrin domain containing 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NLRP9B mRNA

NCBI chr 1:68,291,180...68,341,512
Ensembl chr 1:68,291,180...68,341,512

G

neuromedin U

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NMU mRNA

NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192

G

nocturnin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA

NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400

G

nucleotide-binding oligomerization domain containing 2

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of NOD2 mRNA

NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177

G

notch receptor 1

affects expression

Cacodylic Acid affects the expression of NOTCH1 mRNA

NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531

G

notch receptor 3

increases expression

Cacodylic Acid results in increased expression of NOTCH3 mRNA

NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025

G

neuronal PAS domain protein 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NPAS4 mRNA

NCBI chr 1:202,281,260...202,298,681
Ensembl chr 1:202,281,958...202,286,724

G

neuropeptide FF receptor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NPFFR1 mRNA

NCBI chr20:29,539,795...29,573,951
Ensembl chr20:29,539,795...29,571,196

G

natriuretic peptide A

increases expression

Cacodylic Acid results in increased expression of NPPA mRNA

NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351

G

neuropeptide Y receptor Y5

decreases expression

Cacodylic Acid results in decreased expression of NPY5R mRNA

NCBI chr16:23,055,427...23,063,384
Ensembl chr16:23,055,427...23,063,382

G

NAD(P)H quinone dehydrogenase 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of NQO1 mRNA
Cacodylic Acid promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; Cacodylic Acid promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of NQO1 protein]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Cacodylic Acid results in increased expression of and results in increased activity of NQO1 protein; NFE2L2 mutant form inhibits the reaction [Cacodylic Acid results in increased expression of NQO1 protein]

PMID:15345372 PMID:24161444

NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557

G

nuclear receptor subfamily 0, group B, member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NR0B2 mRNA

NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609

G

neuregulin 1

increases expression

Cacodylic Acid results in increased expression of NRG1 mRNA

NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884

G

neuropilin 2

decreases expression

Cacodylic Acid results in decreased expression of NRP2 mRNA

NCBI chr 9:64,122,815...64,238,007
Ensembl chr 9:64,123,132...64,237,958

G

5' nucleotidase, ecto

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NT5E mRNA

NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881

G

NUF2 component of NDC80 kinetochore complex

increases expression

Cacodylic Acid results in increased expression of NUF2 mRNA

NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766

G

nuclear GTPase, germinal center associated

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NUGGC mRNA

NCBI chr15:39,821,851...39,866,122
Ensembl chr15:39,821,855...39,866,122

G

neurexophilin and PC-esterase domain family, member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE3 mRNA

NCBI chr11:44,726,905...44,777,694
Ensembl chr11:44,727,069...44,777,694

G

neurexophilin and PC-esterase domain family member 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE4 mRNA

NCBI chr 8:48,502,697...48,744,101
Ensembl chr 8:48,722,440...48,744,100

G

nyctalopin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NYX mRNA

NCBI chr X:9,280,864...9,301,900
Ensembl chr X:9,280,864...9,301,900

G

2'-5' oligoadenylate synthetase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OAS2 mRNA

NCBI chr12:35,802,824...35,830,778
Ensembl chr12:35,806,759...35,829,371

G

ornithine decarboxylase antizyme 1

decreases expression

Cacodylic Acid results in decreased expression of OAZ1 mRNA

NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:8,883,851...8,886,310

G

8-oxoguanine DNA glycosylase

multiple interactions
increases expression

OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA1B mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA4L mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA8 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPB1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPH1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of AOC3 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CCNC mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CDH4 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CFD mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CYP7B1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of KPNB1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of MMP13 mRNA]
Cacodylic Acid results in increased expression of OGG1 mRNA

PMID:17441966 PMID:17481689

NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766

G

osteoglycin

decreases expression

Cacodylic Acid results in decreased expression of OGN mRNA

NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739

G

olfactomedin-like 2B

decreases expression

Cacodylic Acid results in decreased expression of OLFML2B mRNA

NCBI chr13:82,869,414...82,906,607
Ensembl chr13:82,869,433...82,906,607

G

opioid binding protein/cell adhesion molecule-like

decreases expression

Cacodylic Acid results in decreased expression of OPCML mRNA

NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:26,192,841...27,300,620

G

olfactory receptor family 10 subfamily J member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OR10J2 mRNA

NCBI chr13:85,723,300...85,724,290
Ensembl chr13:85,719,234...85,724,767

G

olfactory receptor family 6 subfamily C member 6I

increases expression

Cacodylic Acid results in increased expression of OR6C6I mRNA

NCBI chr 7:1,969,945...1,970,889
Ensembl chr 7:1,969,945...1,970,889

G

odd-skipped related transciption factor 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA

NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224

G

3-oxoacid CoA transferase 2A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OXCT2A mRNA

NCBI chr 5:135,600,812...135,602,570
Ensembl chr 5:135,591,507...135,602,569

G

P2Y receptor family member 10

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of P2RY10 mRNA

NCBI chr X:72,121,558...72,207,174
Ensembl chr X:72,111,264...72,212,265

G

purinergic receptor P2Y13

decreases expression

Cacodylic Acid results in decreased expression of P2RY13 mRNA

NCBI chr 2:143,470,437...143,476,360
Ensembl chr 2:143,470,425...143,473,434

G

prolyl 4-hydroxylase subunit alpha 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of P4HA1 mRNA

NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786

G

protein kinase C and casein kinase substrate in neurons 2

increases expression

Cacodylic Acid results in increased expression of PACSIN2 mRNA

NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:114,505,152...114,598,546

G

p21 (RAC1) activated kinase 2

decreases expression

Cacodylic Acid results in decreased expression of PAK2 mRNA

NCBI chr11:68,707,940...68,768,816
Ensembl chr11:68,707,969...68,768,816

G

pappalysin

increases expression

Cacodylic Acid results in increased expression of PAPPA mRNA

NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666

G

parvin, gamma

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PARVG mRNA

NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:115,456,209...115,475,104

G

paired box 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PAX5 mRNA

NCBI chr 5:58,763,334...58,945,719
Ensembl chr 5:58,765,036...58,944,326

G

paired box 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PAX6 mRNA

NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014

G

protocadherin 1

decreases expression

Cacodylic Acid results in decreased expression of PCDH1 mRNA

NCBI chr18:30,011,692...30,039,679
Ensembl chr18:30,013,185...30,039,318

G

protocadherin related 15

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDH15 mRNA

NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,963,565...15,494,719

G

protocadherin gamma subfamily B, 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDHGB1 mRNA

NCBI chr18:29,501,739...29,508,024

G

PC-esterase domain containing 1B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCED1B mRNA

NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:128,391,319...128,528,231

G

phosphoenolpyruvate carboxykinase 1

increases expression

Cacodylic Acid results in increased expression of PCK1 mRNA

NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191

G

proliferating cell nuclear antigen

increases expression

Cacodylic Acid results in increased expression of PCNA mRNA; Cacodylic Acid results in increased expression of PCNA protein

PMID:17481689 PMID:24832369

NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995

G

proprotein convertase subtilisin/kexin type 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA

NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688

G

programmed cell death 2

increases expression

Cacodylic Acid results in increased expression of PDCD2 mRNA

NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:56,463,931...56,490,437

G

phosphodiesterase 3B

decreases expression

Cacodylic Acid results in decreased expression of PDE3B mRNA

NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334

G

platelet derived growth factor receptor alpha

decreases expression

Cacodylic Acid results in decreased expression of PDGFRA mRNA

NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335

G

pyruvate dehydrogenase kinase 4

decreases expression
increases expression

Cacodylic Acid results in decreased expression of PDK4 mRNA
Cacodylic Acid results in increased expression of PDK4 mRNA

PMID:16122865 PMID:37567419

NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850

G

period circadian regulator 1

decreases expression

Cacodylic Acid results in decreased expression of PER1 mRNA

NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431

G

phosphate regulating endopeptidase X-linked

decreases expression

Cacodylic Acid results in decreased expression of PHEX mRNA

NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469

G

pleckstrin homology-like domain, family A, member 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PHLDA1 mRNA

NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861

G

peptidase inhibitor 15

decreases expression

Cacodylic Acid results in decreased expression of PI15 mRNA

NCBI chr 5:1,395,094...1,423,213
Ensembl chr 5:1,395,094...1,423,213

G

paired-like homeodomain 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PITX1 mRNA

NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291

G

phospholipase A2 group IB

decreases expression

Cacodylic Acid results in decreased expression of PLA2G1B mRNA

NCBI chr12:41,142,193...41,151,967
Ensembl chr12:41,142,200...41,153,226

G

phospholipase A2 group IIA

multiple interactions
decreases expression

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA
Cacodylic Acid results in decreased expression of PLA2G2A mRNA

PMID:34876320 PMID:37567419

NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014

G

phospholipase A2, group IID

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA

NCBI chr 5:151,016,010...151,022,531
Ensembl chr 5:151,018,870...151,022,525

G

phospholipase A2, group IVF

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA

NCBI chr 3:107,249,053...107,266,201
Ensembl chr 3:107,250,075...107,264,689

G

phospholipase A2 group VII

increases expression

Cacodylic Acid results in increased expression of PLA2G7 mRNA

NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476

G

PLAG1 like zinc finger 1

decreases expression

Cacodylic Acid results in decreased expression of PLAGL1 mRNA

NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228

G

plasminogen activator, urokinase

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PLAU mRNA

NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775

G

plasminogen activator, urokinase receptor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLAUR mRNA

NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595

G

phospholipase B1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLB1 mRNA

NCBI chr 6:24,087,051...24,227,167
Ensembl chr 6:24,089,214...24,210,117

G

phospholipase D2

increases expression

Cacodylic Acid results in increased expression of PLD2 mRNA

NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808

G

phospholipase D family, member 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLD4 mRNA

NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376

G

pleckstrin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLEK mRNA

NCBI chr14:91,397,015...91,429,693
Ensembl chr14:91,397,019...91,454,131

G

pleckstrin homology and RhoGEF domain containing G4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLEKHG4 mRNA

NCBI chr19:33,251,788...33,266,490
Ensembl chr19:33,249,706...33,266,357

G

pleckstrin homology, MyTH4 and FERM domain containing H2

decreases expression

Cacodylic Acid results in decreased expression of PLEKHH2 mRNA

NCBI chr 6:10,032,837...10,132,081
Ensembl chr 6:10,032,660...10,140,794

G

placenta expressed transcript 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLET1 mRNA

NCBI chr 8:50,842,242...50,853,666
Ensembl chr 8:50,841,854...50,853,659

G

polo-like kinase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLK3 mRNA

NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317

G

phospholipid transfer protein

decreases expression

Cacodylic Acid results in decreased expression of PLTP mRNA

NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647

G

plexin C1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLXNC1 mRNA

NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779

G

phorbol-12-myristate-13-acetate-induced protein 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PMAIP1 mRNA

NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429

G

patatin-like phospholipase domain containing 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA1 mRNA

NCBI chr20:6,917,993...6,952,157
Ensembl chr20:6,917,931...6,952,375

G

patatin-like phospholipase domain containing 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA3 mRNA

NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077

G

DNA polymerase alpha 1, catalytic subunit

increases expression

Cacodylic Acid results in increased expression of POLA1 mRNA

NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536

G

DNA polymerase delta 1, catalytic subunit

increases expression

Cacodylic Acid results in increased expression of POLD1 mRNA

NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465

G

DNA polymerase delta 4, accessory subunit

increases expression

Cacodylic Acid results in increased expression of POLD4 mRNA

NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401

G

DNA polymerase epsilon 2, accessory subunit

increases expression

Cacodylic Acid results in increased expression of POLE2 mRNA

NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305

G

DNA polymerase gamma, catalytic subunit

increases expression

Cacodylic Acid results in increased expression of POLG mRNA

NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567

G

DNA polymerase iota

increases expression

Cacodylic Acid results in increased expression of POLI mRNA

NCBI chr18:64,116,774...64,134,373
Ensembl chr18:64,116,774...64,163,418

G

paraoxonase 1

increases expression

Cacodylic Acid results in increased expression of PON1 mRNA

NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360

G

POU class 2 homeobox associating factor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2AF1 mRNA

NCBI chr 8:51,521,813...51,548,819
Ensembl chr 8:51,474,015...51,548,819

G

POU class 2 homeobox 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2F2 mRNA

NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261

G

POU class 3 homeobox 1

decreases expression

Cacodylic Acid results in decreased expression of POU3F1 mRNA

NCBI chr 5:136,910,391...136,913,371
Ensembl chr 5:136,910,391...136,913,371

G

peroxisome proliferator-activated receptor gamma

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of PPARG mRNA
[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA

PMID:23221991 PMID:28793237

NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468

G

protein phosphatase 1, regulatory subunit 16B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PPP1R16B mRNA

NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937

G

PRAME like 34

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRAMEL34 mRNA

NCBI chr14:13,850,057...13,852,806
Ensembl chr14:13,850,057...13,852,806

G

protein regulator of cytokinesis 1

increases expression

Cacodylic Acid results in increased expression of PRC1 mRNA

NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765

G

peroxiredoxin 2

increases expression

Cacodylic Acid results in increased expression of PRDX2 mRNA

NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194

G

prolactin regulatory element binding

increases expression

Cacodylic Acid results in increased expression of PREB mRNA

NCBI chr 6:25,418,805...25,422,594
Ensembl chr 6:25,418,776...25,422,590

G

protein kinase C, alpha

increases expression

Cacodylic Acid results in increased expression of PRKCA mRNA

NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012

G

protein kinase C, gamma

increases expression

Cacodylic Acid results in increased expression of PRKCG mRNA

NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384

G

protein kinase C, zeta

increases expression

Cacodylic Acid results in increased expression of PRKCZ mRNA

NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367

G

prominin 1

increases expression

Cacodylic Acid results in increased expression of PROM1 mRNA

NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527

G

proline rich 5 like

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA

NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:88,003,617...88,082,763

G

serine protease 16

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PRSS16 mRNA

NCBI chr17:42,514,306...42,521,885
Ensembl chr17:42,514,306...42,521,884

G

prostate stem cell antigen

increases expression

Cacodylic Acid results in increased expression of PSCA mRNA

NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746

G

prostaglandin F receptor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTGFR mRNA

NCBI chr 2:240,731,185...240,766,674
Ensembl chr 2:240,733,375...240,765,650

G

prostaglandin-endoperoxide synthase 2

increases expression

Cacodylic Acid results in increased expression of PTGS2 mRNA; Cacodylic Acid results in increased expression of PTGS2 protein

PMID:12151359 PMID:24832369 PMID:32890875

NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188

G

protein tyrosine kinase 2 beta

increases expression

Cacodylic Acid results in increased expression of PTK2B mRNA

NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282

G

protein tyrosine phosphatase, non-receptor type 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPN7 mRNA

NCBI chr13:46,570,904...46,584,048
Ensembl chr13:46,571,712...46,583,308

G

protein tyrosine phosphatase, receptor type, C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRC mRNA

NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692

G

protein tyrosine phosphatase, receptor type, C-associated protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRCAP mRNA

NCBI chr 1:201,449,133...201,451,293
Ensembl chr 1:201,449,113...201,451,288

G

pyroglutamylated RFamide peptide receptor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of QRFPR mRNA

NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:119,053,511...119,096,792

G

RAB10, member RAS oncogene family

increases expression

Cacodylic Acid results in increased expression of RAB10 mRNA

NCBI chr 6:26,267,081...26,319,739
Ensembl chr 6:26,266,859...26,320,193

G

RAB14, member RAS oncogene family

increases expression
decreases expression

Cacodylic Acid results in increased expression of RAB14 mRNA
Cacodylic Acid results in decreased expression of RAB14 mRNA

PMID:16122865 PMID:17720352

NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:18,501,963...18,523,172

G

RAB1A, member RAS oncogene family

increases expression

Cacodylic Acid results in increased expression of RAB1A mRNA

NCBI chr14:94,422,219...94,448,799
Ensembl chr14:94,415,275...94,448,248

G

RAB33A, member RAS oncogene family

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RAB33A mRNA

NCBI chr X:127,694,219...127,706,378
Ensembl chr X:127,694,964...127,706,378

G

RAB7A, member RAS oncogene family

decreases expression
increases expression

Cacodylic Acid results in decreased expression of RAB7 mRNA
Cacodylic Acid results in increased expression of RAB7 mRNA

PMID:16122865 PMID:17720352

NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:120,461,963...120,506,889

G

RAD51 paralog C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA

NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248

G

RPA1 related single stranded DNA binding protein, X-linked

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RADX mRNA

NCBI chr X:103,089,284...103,176,840
Ensembl chr X:103,089,284...103,176,838

G

Raf-1 proto-oncogene, serine/threonine kinase

multiple interactions
increases expression

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RAF1 mRNA
Cacodylic Acid results in increased expression of RAF1 protein

PMID:23192986 PMID:32890875

NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317

G

ral guanine nucleotide dissociation stimulator

increases expression

Cacodylic Acid results in increased expression of RALGDS mRNA

NCBI chr 3:11,839,686...11,880,059
Ensembl chr 3:11,839,416...11,880,059

G

ral guanine nucleotide dissociation stimulator like 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGL3 mRNA

NCBI chr 8:20,500,846...20,520,471
Ensembl chr 8:20,500,846...20,520,471

G

receptor activity modifying protein 1

increases expression

Cacodylic Acid results in increased expression of RAMP1 mRNA

NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151

G

RAN, member RAS oncogene family

increases expression

Cacodylic Acid results in increased expression of RAN mRNA

NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276

G

retinoic acid receptor responder 2

decreases expression

Cacodylic Acid results in decreased expression of RARRES2 mRNA

NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556

G

RAS protein activator like 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASAL3 mRNA

NCBI chr 7:11,396,554...11,411,347
Ensembl chr 7:11,396,090...11,411,465

G

ras related dexamethasone induced 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASD1 mRNA

NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186

G

RAS guanyl releasing protein 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA

NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578

G

RAS-like family 11 member A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA

NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576

G

REC114 meiotic recombination protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC114 mRNA

NCBI chr 8:59,063,352...59,221,439
Ensembl chr 8:59,063,352...59,149,887

G

REC8 meiotic recombination protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC8 mRNA

NCBI chr15:29,109,862...29,117,327
Ensembl chr15:29,109,863...29,117,326

G

receptor accessory protein 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REEP6 mRNA

NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597

G

regenerating family member 3 beta

decreases expression
multiple interactions

Cacodylic Acid results in decreased expression of REG3B mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3B mRNA

PMID:16122865 PMID:34876320

NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015

G

regenerating family member 3 gamma

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3G mRNA

NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:110,924,168...110,926,723

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RELA mRNA

NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484

G

RELT-like 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA

NCBI chr18:29,789,996...29,793,986
Ensembl chr18:29,790,415...29,793,986

G

regulator of G-protein signaling 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGS1 mRNA

NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984

G

ras homolog family member H

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RHOH mRNA

NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,337,751...42,386,369

G

ras homolog family member J

decreases expression

Cacodylic Acid results in decreased expression of RHOJ mRNA

NCBI chr 6:94,035,307...94,117,642
Ensembl chr 6:94,035,483...94,118,275

G

receptor-interacting serine-threonine kinase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA

NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121

G

RHO family interacting cell polarization regulator 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA

NCBI chr17:40,323,748...40,547,482
Ensembl chr17:40,323,867...40,548,092

G

ribonuclease A family member k6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA

NCBI chr15:24,354,305...24,357,289
Ensembl chr15:24,354,303...24,357,328

G

ring finger protein 225

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF225 mRNA

NCBI chr 1:73,543,598...73,546,269
Ensembl chr 1:73,543,598...73,546,269

G

ring finger protein 24

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF24 mRNA

NCBI chr 3:118,520,459...118,575,213
Ensembl chr 3:118,525,349...118,541,080

G

Rho-associated coiled-coil containing protein kinase 1

decreases expression

Cacodylic Acid results in decreased expression of ROCK1 mRNA

NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571

G

Rho-associated coiled-coil containing protein kinase 2

increases expression

Cacodylic Acid results in increased expression of ROCK2 mRNA

NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031

G

ROS proto-oncogene 1 , receptor tyrosine kinase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ROS1 mRNA

NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,432,637...31,583,865

G

ribonuclease P RNA component H1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RPPH1 mRNA

NCBI chr15:24,033,679...24,033,935
Ensembl chr15:24,033,662...24,033,959

G

ribonucleotide reductase regulatory subunit M2

increases expression

Cacodylic Acid results in increased expression of RRM2 mRNA

NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773

G

radical S-adenosyl methionine domain containing 2

increases expression

Cacodylic Acid results in increased expression of RSAD2 mRNA

NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699

G

ribosomal protein S6 kinase related

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RSKR mRNA

NCBI chr10:63,185,286...63,191,963
Ensembl chr10:63,156,044...63,191,141

G

RT1 class II, locus Da

decreases expression

Cacodylic Acid results in decreased expression of RT1-DA mRNA

NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455

G

RT1 class II, locus DOa

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA

NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,753,598...4,756,577

G

RT1 class II, locus DOb

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OB mRNA

NCBI chr20:4,619,418...4,625,627
Ensembl chr20:4,619,816...4,625,667

G

rubicon like autophagy enhancer

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA

NCBI chr15:50,332,458...50,377,494
Ensembl chr15:50,332,418...50,400,849

G

ryanodine receptor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR1 mRNA

NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812

G

ryanodine receptor 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR3 mRNA

NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:99,432,505...99,704,961

G

S100 calcium binding protein G

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S100G mRNA

NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433

G

sphingosine-1-phosphate receptor 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA

NCBI chr 7:8,207,767...8,210,043
Ensembl chr 7:8,208,098...8,211,893

G

sacsin molecular chaperone

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SACS mRNA

NCBI chr15:35,285,783...35,370,335
Ensembl chr15:35,285,782...35,370,335

G

sterile alpha motif domain containing 4A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMD4 mRNA

NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380

G

SAM domain, SH3 domain and nuclear localization signals, 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMSN1 mRNA

NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900

G

SAM and SH3 domain containing 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SASH3 mRNA

NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519

G

sciellin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA

NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372

G

sodium voltage-gated channel alpha subunit 2

decreases expression

Cacodylic Acid results in decreased expression of SCN2A mRNA

NCBI chr 3:50,302,781...50,437,504
Ensembl chr 3:50,302,877...50,437,214

G

sodium voltage-gated channel alpha subunit 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCN4A mRNA

NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,246,936...91,296,545

G

sterol carrier protein 2

decreases expression

Cacodylic Acid results in decreased expression of SCP2 mRNA

NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287

G

signal peptide, CUB domain and EGF like domain containing 2

decreases expression

Cacodylic Acid results in decreased expression of SCUBE2 mRNA

NCBI chr 1:163,831,876...163,899,925
Ensembl chr 1:163,832,015...163,899,393

G

secreted and transmembrane 1B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA

NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769

G

selenium binding protein 1

decreases expression

Cacodylic Acid results in decreased expression of SELENBP1 mRNA

NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594

G

selectin L

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SELL mRNA

NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456

G

semaphorin 7A (John Milton Hagen blood group)

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA

NCBI chr 8:58,348,448...58,370,536
Ensembl chr 8:58,348,448...58,370,536

G

serpin family B member 8

increases expression

Cacodylic Acid results in increased expression of SERPINB8 mRNA

NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835

G

serpin family C member 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SERPINC1 mRNA

NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293

G

serpin family F member 1

decreases expression

Cacodylic Acid results in decreased expression of SERPINF1 mRNA

NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646

G

serpin family F member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SERPINF2 mRNA

NCBI chr10:60,272,400...60,280,506
Ensembl chr10:60,272,400...60,281,243

G

serpin family G member 1

multiple interactions
decreases expression

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of SERPING1 mRNA
Cacodylic Acid results in decreased expression of SERPING1 mRNA

PMID:28793237 PMID:37567419

NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034

G

secreted frizzled-related protein 2

decreases expression

Cacodylic Acid results in decreased expression of SFRP2 mRNA

NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063

G

secreted frizzled-related protein 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SFRP4 mRNA

NCBI chr17:45,278,867...45,330,806
Ensembl chr17:45,234,097...45,330,736

G

serum/glucocorticoid regulated kinase 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of SGK1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SGK1 mRNA

PMID:16122865 PMID:34876320

NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283

G

shugoshin 2

increases expression

Cacodylic Acid results in increased expression of SGO2 mRNA

NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229

G

SH3 domain binding glutamate-rich protein like 3

decreases expression

Cacodylic Acid results in decreased expression of SH3BGRL3 mRNA

NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331

G

SH3 domain containing 21

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SH3D21 mRNA

NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:138,429,180...138,444,407

G

shisa family member 6

decreases expression

Cacodylic Acid results in decreased expression of SHISA6 mRNA

NCBI chr10:50,897,740...51,192,111
Ensembl chr10:50,903,333...51,192,063

G

SHQ1, H/ACA ribonucleoprotein assembly factor

decreases expression

Cacodylic Acid results in decreased expression of SHQ1 mRNA

NCBI chr 4:133,213,357...133,305,586
Ensembl chr 4:133,213,361...133,305,586

G

shroom family member 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SHROOM4 mRNA

NCBI chr X:15,869,065...16,076,850
Ensembl chr X:15,869,065...16,076,869

G

signaling lymphocytic activation molecule family member 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA

NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497

G

SLAM family member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF6 mRNA

NCBI chr13:84,384,561...84,405,300
Ensembl chr13:84,383,742...84,405,300

G

SLAM family member 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF7 mRNA

NCBI chr13:84,135,656...84,154,528
Ensembl chr13:84,136,899...84,154,105

G

solute carrier family 10 member 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A1 mRNA

NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670

G

solute carrier family 10 member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A6 mRNA

NCBI chr14:6,080,716...6,102,902
Ensembl chr14:6,080,717...6,103,037

G

solute carrier family 11 member 2

decreases expression

Cacodylic Acid results in decreased expression of SLC11A2 mRNA

NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145

G

solute carrier family 13 member 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC13A1 mRNA

NCBI chr 4:52,569,179...52,647,126
Ensembl chr 4:52,569,375...52,647,099

G

solute carrier family 14 member 1 (Kidd blood group)

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC14A1 mRNA

NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146

G

solute carrier family 15 member 4

decreases expression

Cacodylic Acid results in decreased expression of SLC15A4 mRNA

NCBI chr12:29,048,634...29,082,480
Ensembl chr12:29,063,015...29,082,480

G

solute carrier family 15, member 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC15A5 mRNA

NCBI chr 4:170,878,021...170,971,620
Ensembl chr 4:170,878,021...170,971,620

G

solute carrier family 16 member 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC16A8 mRNA

NCBI chr 7:110,818,274...110,822,069
Ensembl chr 7:110,818,274...110,822,069

G

solute carrier family 26 member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA

NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626

G

solute carrier family 27 member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC27A3 mRNA

NCBI chr 2:175,853,241...175,857,909
Ensembl chr 2:175,853,241...175,857,909

G

solute carrier family 27 member 6

decreases expression

Cacodylic Acid results in decreased expression of SLC27A6 mRNA

NCBI chr18:52,040,241...52,099,622
Ensembl chr18:52,041,074...52,099,414

G

solute carrier family 28 member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A2 mRNA

NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702

G

solute carrier family 28 member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A3 mRNA

NCBI chr17:6,062,563...6,112,965
Ensembl chr17:6,062,549...6,114,038

G

solute carrier family 29 member 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC29A4 mRNA

NCBI chr12:11,853,540...11,884,660
Ensembl chr12:11,853,540...11,874,834

G

solute carrier family 2 member 4

increases expression

Cacodylic Acid results in increased expression of SLC2A4 mRNA

NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565

G

solute carrier family 2 member 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA

NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106

G

solute carrier family 34 member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA

NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436

G

solute carrier family 35 member D1

increases expression

Cacodylic Acid results in increased expression of SLC35D1 mRNA

NCBI chr 5:117,928,628...117,981,289
Ensembl chr 5:117,934,352...117,981,311

G

solute carrier family 38, member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC38A3 mRNA

NCBI chr 8:108,323,889...108,339,959
Ensembl chr 8:108,323,894...108,339,988

G

solute carrier family 38, member 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC38A8 mRNA

NCBI chr19:47,522,781...47,561,443
Ensembl chr19:47,525,301...47,554,726

G

solute carrier family 39 member 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA

NCBI chr15:24,590,738...24,592,850
Ensembl chr15:24,590,738...24,592,850

G

solute carrier family 41, member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC41A3 mRNA

NCBI chr 4:123,109,555...123,154,766
Ensembl chr 4:123,112,748...123,154,766

G

solute carrier family 5 member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC5A3 mRNA

NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883

G

solute carrier family 5 member 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC5A9 mRNA

NCBI chr 5:126,709,762...126,733,468
Ensembl chr 5:126,709,769...126,733,468

G

solute carrier family 6 member 14

increases expression

Cacodylic Acid results in increased expression of SLC6A14 mRNA

NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096

G

solute carrier family 6 member 18

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC6A18 mRNA

NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925

G

solute carrier family 6 member 6

increases expression

Cacodylic Acid results in increased expression of SLC6A6 mRNA

NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875

G

solute carrier family 7 member 11

increases expression

Cacodylic Acid results in increased expression of SLC7A11 mRNA

NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536

G

solute carrier family 7 member 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC7A9 mRNA

NCBI chr 1:88,109,517...88,132,653
Ensembl chr 1:88,110,644...88,132,641

G

solute carrier family 8 member A3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC8A3 mRNA

NCBI chr 6:100,874,359...101,007,989
Ensembl chr 6:100,874,369...101,007,508

G

solute carrier family 9 member A3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC9A3 mRNA

NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417

G

solute carrier organic anion transporter family, member 5A1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLCO5A1 mRNA

NCBI chr 5:6,228,938...6,358,124
Ensembl chr 5:6,228,973...6,352,913

G

synuclein alpha

decreases expression

Cacodylic Acid results in decreased expression of SNCA

NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262

G

stannin

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SNN mRNA

NCBI chr10:4,572,933...4,581,606
Ensembl chr10:4,572,376...4,584,021

G

small nucleolar RNA, H/ACA box 69

increases expression

Cacodylic Acid results in increased expression of SNORA69 mRNA

NCBI chr20:43,610,465...43,610,598
Ensembl chr20:43,610,465...43,610,598

G

sterol O-acyltransferase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SOAT2 mRNA

NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915

G

superoxide dismutase 1

increases expression
decreases expression

Cacodylic Acid results in increased expression of SOD1 mRNA
Cacodylic Acid results in decreased expression of SOD1 mRNA

PMID:16122865 PMID:17441966

NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249

G

sperm associated antigen 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPAG1 mRNA

NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368

G

spermatogenesis associated 6-like

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SPATA6L mRNA

NCBI chr 1:226,630,470...226,682,979
Ensembl chr 1:226,641,518...226,682,884

G

spermatogenesis associated, serine-rich 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPATS1 mRNA

NCBI chr 9:15,527,179...15,562,286
Ensembl chr 9:15,527,142...15,562,280

G

spondin 1

decreases expression

Cacodylic Acid results in decreased expression of SPON1 mRNA

NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226

G

small proline-rich protein 1A

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR1A mRNA

NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063

G

sprouty RTK signaling antagonist 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA

NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,436,443...30,453,004

G

serine palmitoyltransferase, small subunit B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPTSSB mRNA

NCBI chr 2:154,133,728...154,162,127
Ensembl chr 2:154,133,733...154,163,120

G

squalene epoxidase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SQLE mRNA

NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618

G

SRC proto-oncogene, non-receptor tyrosine kinase

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of SRC mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of SRC protein

PMID:23192986 PMID:32890875

NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476

G

sterol regulatory element binding transcription factor 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SREBF2 mRNA

NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848

G

SRSF protein kinase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SRPK3 mRNA

NCBI chr X:151,510,452...151,515,208
Ensembl chr X:151,510,539...151,515,198

G

sushi-repeat-containing protein, X-linked

decreases expression

Cacodylic Acid results in decreased expression of SRPX mRNA

NCBI chr X:12,676,984...12,751,296
Ensembl chr X:12,566,645...12,747,882

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA

NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:33,415,671...33,524,389

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA

NCBI chr 2:242,129,755...242,645,120
Ensembl chr 2:242,129,763...242,645,133

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA4 mRNA

NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:95,993,503...96,084,653

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA

NCBI chr17:76,740,755...76,884,178
Ensembl chr17:76,745,224...76,884,299

G

signal transducing adaptor family member 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA

NCBI chr14:21,950,466...21,981,395
Ensembl chr14:21,952,496...21,981,245

G

signal transducer and activator of transcription 3

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of STAT3 mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of STAT3 protein

PMID:23192986 PMID:32890875

NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057

G

stanniocalcin 1

decreases expression

Cacodylic Acid results in decreased expression of STC1 mRNA

NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264

G

stathmin 2

decreases expression

Cacodylic Acid results in decreased expression of STMN2 mRNA

NCBI chr 2:93,204,690...93,252,011
Ensembl chr 2:93,204,692...93,252,011

G

sulfotransferase family 1B member 1

increases expression

Cacodylic Acid results in increased expression of SULT1B1 mRNA

NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483

G

sushi domain containing 2

decreases expression

Cacodylic Acid results in decreased expression of SUSD2 mRNA

NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903

G

sushi domain containing 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SUSD3 mRNA

NCBI chr17:15,400,845...15,417,851
Ensembl chr17:15,400,845...15,417,044

G

synaptonemal complex protein 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYCP2 mRNA

NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:165,436,331...165,498,789

G

synaptotagmin 5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SYT5 mRNA

NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067

G

synaptotagmin 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYT8 mRNA

NCBI chr 1:197,588,126...197,593,598
Ensembl chr 1:197,590,149...197,593,504

G

TBC1 domain family, member 10C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TBC1D10C mRNA

NCBI chr 1:201,476,258...201,484,876
Ensembl chr 1:201,477,157...201,564,920

G

T-box transcription factor 20

decreases expression

Cacodylic Acid results in decreased expression of TBX20 mRNA

NCBI chr 8:23,200,104...23,258,218
Ensembl chr 8:23,204,507...23,258,175

G

transcription factor 23

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TCF23 mRNA

NCBI chr 6:25,397,889...25,406,639
Ensembl chr 6:25,397,937...25,405,880

G

transcription factor 24

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCF24 mRNA

NCBI chr 5:9,274,659...9,282,876
Ensembl chr 5:9,227,131...9,279,636

G

t-complex protein 10b

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCP10A mRNA

NCBI chr 1:52,937,823...52,961,307
Ensembl chr 1:52,937,917...52,961,307

G

terminal nucleotidyltransferase 5B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TENT5B mRNA

NCBI chr 5:145,695,358...145,702,668
Ensembl chr 5:145,695,362...145,706,073

G

transferrin receptor

increases expression

Cacodylic Acid results in increased expression of TFRC mRNA

NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257

G

transforming growth factor alpha

increases expression

Cacodylic Acid results in increased expression of TGFA mRNA

NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894

G

transforming growth factor, beta 1

multiple interactions
increases secretion

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TGFB1 mRNA
Cacodylic Acid results in increased secretion of TGFB1 protein

PMID:23192986 PMID:24832369

NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847

G

transforming growth factor, beta induced

decreases expression

Cacodylic Acid results in decreased expression of TGFBI mRNA

NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240

G

transforming growth factor, beta receptor 1

decreases expression

Cacodylic Acid results in decreased expression of TGFBR1 mRNA

NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777

G

transforming growth factor, beta receptor 2

increases expression

Cacodylic Acid results in increased expression of TGFBR2 mRNA

NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228

G

transglutaminase 2

decreases expression

Cacodylic Acid results in decreased expression of TGM2 mRNA

NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981

G

transglutaminase 7

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TGM7 mRNA

NCBI chr 3:108,051,890...108,068,116
Ensembl chr 3:108,051,890...108,076,239

G

thrombomodulin

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of THBD mRNA

NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193

G

thrombospondin 2

decreases expression

Cacodylic Acid results in decreased expression of THBS2 mRNA

NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789

G

thymocyte selection associated

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of THEMIS mRNA

NCBI chr 1:16,433,906...16,623,889
Ensembl chr 1:16,432,631...16,664,329

G

Thy-1 cell surface antigen

multiple interactions
decreases expression

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of THY1 mRNA
Cacodylic Acid results in decreased expression of THY1 mRNA

PMID:28793237 PMID:37567419

NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659

G

TRAF-interacting protein with forkhead-associated domain

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TIFA mRNA

NCBI chr 2:216,257,926...216,267,635
Ensembl chr 2:216,234,774...216,267,841

G

toll-like receptor 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TLR8 mRNA

NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549

G

toll-like receptor 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TLR9 mRNA

NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796

G

transmembrane 4 L six family member 20

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TM4SF20 mRNA

NCBI chr 9:84,038,715...84,052,615
Ensembl chr 9:84,038,715...84,052,615

G

transmembrane p24 trafficking protein 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA

NCBI chr19:34,966,813...34,972,900
Ensembl chr19:34,966,813...34,972,900

G

transmembrane protein 140

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMEM140 mRNA

NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:63,536,168...63,548,455

G

transmembrane protein 156

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA

NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,223,381...43,252,449

G

transmembrane protein 17

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM17 mRNA

NCBI chr14:96,483,648...96,524,238
Ensembl chr14:96,518,793...96,524,233

G

transmembrane protein 266

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM266 mRNA

NCBI chr 8:55,707,122...55,820,692
Ensembl chr 8:55,707,122...55,820,692

G

transmembrane protein 71

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM71 mRNA

NCBI chr 7:98,276,975...98,323,161
Ensembl chr 7:98,276,975...98,315,858

G

transmembrane protein 98

decreases expression

Cacodylic Acid results in decreased expression of TMEM98 mRNA

NCBI chr10:65,796,173...65,807,082
Ensembl chr10:65,796,145...65,807,079

G

tenascin C

decreases expression

Cacodylic Acid results in decreased expression of TNC mRNA

NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624

G

tumor necrosis factor

decreases secretion
decreases expression

Cacodylic Acid results in decreased secretion of TNF protein
Cacodylic Acid results in decreased expression of TNF protein

PMID:9548797 PMID:24832369

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

G

TNF receptor superfamily member 13B

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13B mRNA

NCBI chr10:45,801,860...45,824,932
Ensembl chr10:45,801,860...45,822,987

G

TNF receptor superfamily member 13C

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA

NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:113,736,055...113,738,517

G

TNF receptor superfamily member 1A

decreases expression

Cacodylic Acid results in decreased expression of TNFRSF1A mRNA

NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591

G

TNF receptor superfamily member 25

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA

NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341

G

TNF superfamily member 10

decreases expression

Cacodylic Acid results in decreased expression of TNFSF10 mRNA

NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135

G

TNF superfamily member 11

multiple interactions

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of TNFSF11 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF11 mRNA

PMID:28793237 PMID:34876320

NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445

G

TNF superfamily member 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF8 mRNA

NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421

G

troponin I2, fast skeletal type

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNI2 mRNA

NCBI chr 1:197,595,012...197,597,554
Ensembl chr 1:197,594,813...197,597,560

G

troponin T3, fast skeletal type

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNT3 mRNA

NCBI chr 1:197,652,535...197,669,736
Ensembl chr 1:197,652,431...197,669,535

G

DNA topoisomerase II alpha

increases expression
decreases expression

Cacodylic Acid results in increased expression of TOP2A mRNA
Cacodylic Acid results in decreased expression of TOP2A mRNA

PMID:17441966 PMID:17720352 PMID:37567419

NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874

G

tumor protein p53

increases expression
multiple interactions

Cacodylic Acid results in increased expression of TP53 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TP53 mRNA

PMID:17720352 PMID:23192986

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

tubulin polymerization promoting protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TPPP mRNA

NCBI chr 1:29,257,111...29,281,134
Ensembl chr 1:29,261,255...29,281,134

G

TPX2, microtubule nucleation factor

increases expression

Cacodylic Acid results in increased expression of TPX2 mRNA

NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468

G

transformer 2 alpha

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRA2A mRNA

NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712

G

TNF receptor-associated factor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF1 mRNA

NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807

G

Tnf receptor-associated factor 3

decreases expression

Cacodylic Acid results in decreased expression of TRAF3 mRNA

NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:130,206,484...130,305,481

G

TRAF3 interacting protein 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA

NCBI chr13:104,694,802...104,719,655
Ensembl chr13:104,694,805...104,719,673

G

tetratricopeptide repeat and ankyrin repeat containing 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRANK1 mRNA

NCBI chr 8:111,275,973...111,355,491
Ensembl chr 8:111,276,354...111,355,092

G

T cell receptor associated transmembrane adaptor 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRAT1 mRNA

NCBI chr11:52,035,750...52,077,805
Ensembl chr11:52,035,750...52,077,805

G

tripartite motif containing 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRIM6 mRNA

NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:158,683,746...158,696,914

G

transient receptor potential cation channel, subfamily C, member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPC3 mRNA

NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855

G

transient receptor potential cation channel, subfamily V, member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV3 mRNA

NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296

G

transient receptor potential cation channel, subfamily V, member 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV6 mRNA

NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:70,507,348...70,523,017

G

thyroid stimulating hormone receptor

decreases expression

Cacodylic Acid results in decreased expression of TSHR mRNA

NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538

G

tetraspanin 32

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TSPAN32 mRNA

NCBI chr 1:198,190,128...198,204,447
Ensembl chr 1:198,190,164...198,204,445

G

tetratricopeptide repeat domain 41

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTC41 mRNA

NCBI chr 7:21,124,909...21,188,191
Ensembl chr 7:21,125,105...21,188,189

G

tubulin tyrosine ligase like 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA

NCBI chr 1:52,967,183...52,976,690
Ensembl chr 1:52,968,408...52,976,697

G

tubulin tyrosine ligase like 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA

NCBI chr 4:146,532,958...146,558,425
Ensembl chr 4:146,533,953...146,557,889

G

tubulin tyrosine ligase like 9

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTLL9 mRNA

NCBI chr 3:141,429,351...141,475,965
Ensembl chr 3:141,429,444...141,475,865

G

titin

increases expression

Cacodylic Acid results in increased expression of TTN mRNA

NCBI chr 3:61,652,432...61,924,912
Ensembl chr 3:61,652,439...61,924,741

G

tweety family member 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTYH3 mRNA

NCBI chr12:13,996,831...14,025,457
Ensembl chr12:13,997,045...14,025,459

G

TXK tyrosine kinase

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA

NCBI chr14:35,463,369...35,519,448
Ensembl chr14:35,463,944...35,519,448

G

thioredoxin 1

increases expression
multiple interactions

Cacodylic Acid results in increased expression of TXN1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXN mRNA

PMID:16122865 PMID:23192986

NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629

G

thioredoxin 2

increases expression

Cacodylic Acid results in increased expression of TXN2 mRNA

NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359

G

thioredoxin reductase 1

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXNRD1 mRNA

NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863

G

ubiquitin D

increases expression

Cacodylic Acid results in increased expression of UBD mRNA

NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639
Ensembl chr20:1,385,864...1,408,639

G

ubiquitin-conjugating enzyme E2D 3

increases expression

Cacodylic Acid results in increased expression of UBE2D3 mRNA

NCBI chr 2:223,868,397...223,899,606
Ensembl chr 2:223,868,730...223,898,081

G

ubiquitin-conjugating enzyme E2G 2

decreases expression

Cacodylic Acid results in decreased expression of UBE2G2 mRNA

NCBI chr20:10,983,734...11,005,468
Ensembl chr20:10,983,742...11,005,447

G

uncoupling protein 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UCP2 mRNA

NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611

G

UDP glucuronosyltransferase 1 family, polypeptide A2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A2 mRNA

NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465

G

UDP glucuronosyltransferase family 1 member A5

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A5 mRNA

NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465

G

UL16 binding protein 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ULBP1 mRNA

NCBI chr 1:1,694,255...1,716,160

G

uroplakin 1A

decreases expression

Cacodylic Acid results in decreased expression of UPK1A mRNA

NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354

G

uroplakin 3B like 1

increases expression

Cacodylic Acid results in increased expression of UPK3BL mRNA

NCBI chr12:20,610,353...20,616,366
Ensembl chr12:20,610,353...20,616,366

G

upstream transcription factor 2, c-fos interacting

increases expression

Cacodylic Acid results in increased expression of USF2 mRNA

NCBI chr 1:86,174,703...86,185,942
Ensembl chr 1:86,174,703...86,185,617

G

ubiquitin specific peptidase 2

increases expression

Cacodylic Acid results in increased expression of USP2 mRNA

NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331

G

ubiquitin specific peptidase 7

increases expression

Cacodylic Acid results in increased expression of USP7 mRNA

NCBI chr10:6,880,684...6,925,355
Ensembl chr10:6,828,795...6,925,355

G

ubiquitously transcribed tetratricopeptide repeat containing, Y-linked

increases expression

Cacodylic Acid results in increased expression of UTY mRNA

NCBI chr Y:942,838...1,105,313
Ensembl chr Y:924,168...1,103,422

G

vascular cell adhesion molecule 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VCAM1 mRNA

NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958

G

vitamin D receptor

decreases expression

Cacodylic Acid results in decreased expression of VDR mRNA

NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677

G

vascular endothelial growth factor A

increases expression
multiple interactions

Cacodylic Acid results in increased expression of VEGFA protein
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VEGFA mRNA

PMID:32890875 PMID:34876320

NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641

G

vascular endothelial growth factor C

increases expression

Cacodylic Acid results in increased expression of VEGFC mRNA

NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848

G

vascular endothelial growth factor D

decreases expression

Cacodylic Acid results in decreased expression of VEGFD mRNA

NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295

G

vanin 1

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VNN1 mRNA

NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395

G

V-set pre-B cell surrogate light chain 3

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VPREB3 mRNA

NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520

G

vacuolar protein sorting 25 homolog

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VPS25 mRNA

NCBI chr10:86,196,062...86,201,606
Ensembl chr10:86,188,812...86,231,829

G

von Willebrand factor A domain containing 5A

increases expression

Cacodylic Acid results in increased expression of VWA5A mRNA

NCBI chr 8:38,815,176...38,848,674
Ensembl chr 8:38,815,210...38,839,112

G

WASP actin nucleation promoting factor

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WAS mRNA

NCBI chr X:14,405,105...14,413,850
Ensembl chr X:14,405,124...14,413,849

G

WDFY family member 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDFY4 mRNA

NCBI chr16:8,221,853...8,450,494
Ensembl chr16:8,221,719...8,450,491

G

WD repeat domain 31

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDR31 mRNA

NCBI chr 5:75,897,074...75,917,461
Ensembl chr 5:75,898,353...75,917,417

G

WD repeat domain 54

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of WDR54 mRNA

NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:115,654,968...115,661,562

G

WD repeat domain 83 opposite strand

decreases expression

Cacodylic Acid results in decreased expression of WDR83OS mRNA

NCBI chr19:23,075,373...23,076,745
Ensembl chr19:23,075,376...23,076,894

G

Wnt family member 1

multiple interactions

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of WNT1 mRNA

NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651

G

X-box binding protein 1

increases expression

Cacodylic Acid results in increased expression of XBP1 mRNA; Cacodylic Acid results in increased expression of XBP1 mRNA alternative form

NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693

G

X inactive specific transcript

decreases expression

Cacodylic Acid results in decreased expression of XIST mRNA

NCBI chr X:68,474,987...68,492,500

G

XK related 8

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA

NCBI chr 5:144,938,061...144,945,195
Ensembl chr 5:144,938,064...144,945,195

G

X-prolyl aminopeptidase 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of XPNPEP2 mRNA

NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223

G

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta

increases expression

Cacodylic Acid results in increased expression of YWHAQ mRNA

NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:40,935,949...40,966,273

G

zeta chain of T cell receptor associated protein kinase 70

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZAP70 mRNA

NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700

G

zinc finger and BTB domain containing 16

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA

NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011

G

zinc finger and BTB domain containing 40

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB40 mRNA

NCBI chr 5:149,216,496...149,283,746
Ensembl chr 5:149,219,677...149,254,415

G

zinc finger CCCH type containing 6

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZC3H6 mRNA

NCBI chr 3:116,203,466...116,254,186
Ensembl chr 3:116,204,197...116,253,282

G

zinc finger DHHC-type palmitoyltransferase 19

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZDHHC19 mRNA

NCBI chr11:68,277,847...68,289,110
Ensembl chr11:68,277,848...68,288,954

G

zinc finger homeobox 2

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFHX2 mRNA

NCBI chr15:28,533,155...28,565,667
Ensembl chr15:28,533,156...28,565,128

G

zinc finger protein 503

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP503 mRNA

NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,313,060...2,316,848

G

zinc finger protein 831

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP831 mRNA

NCBI chr 3:163,393,787...163,510,654
Ensembl chr 3:163,438,006...163,509,095

G

ZFP92 zinc finger protein

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP92 mRNA

NCBI chr X:151,116,794...151,142,451
Ensembl chr X:151,117,102...151,143,177

G

zinc finger protein 950

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFP950 mRNA

NCBI chr 1:260,248,231...260,265,211
Ensembl chr 1:260,236,599...260,265,254

G

zinc finger, matrin type 4

multiple interactions

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZMAT4 mRNA

NCBI chr16:67,969,410...68,361,377
Ensembl chr16:67,969,416...68,361,202

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	19811
role	19818
biological role	19785
biochemical role	19496
metabolite	19484
xenobiotic metabolite	15429
dimethylarsinic acid	995
Path 2
Term	Annotations
CHEBI ontology	19811
subatomic particle	19809
composite particle	19809
hadron	19840
baryon	19809
nucleon	19809
atomic nucleus	19809
atom	19809
main group element atom	19759
p-block element atom	19759
chalcogen	19515
oxygen atom	19520
oxygen molecular entity	19490
hydroxides	19300
oxoacid	18725
pnictogen oxoacid	13221
arsenic oxoacid	4233
arsinic acid	996
dimethylarsinic acid	995

paths to the root